<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T08:08:10Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3413235" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:3413235</identifier>
        <datestamp>2013-09-01</datestamp>
        <setSpec>jlr</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Lipid Res</journal-id>
              <journal-id journal-id-type="iso-abbrev">J. Lipid Res</journal-id>
              <journal-id journal-id-type="publisher-id">jlr</journal-id>
              <journal-title-group>
                <journal-title>Journal of Lipid Research</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0022-2275</issn>
              <issn pub-type="epub">1539-7262</issn>
              <publisher>
                <publisher-name>The American Society for Biochemistry and Molecular
Biology</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC3413235</article-id>
              <article-id pub-id-type="pmcid">PMC3413235</article-id>
              <article-id pub-id-type="pmc-uid">3413235</article-id>
              <article-id pub-id-type="pmid">22773687</article-id>
              <article-id pub-id-type="pmid">22773687</article-id>
              <article-id pub-id-type="publisher-id">p024315</article-id>
              <article-id pub-id-type="doi">10.1194/jlr.P024315</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Patient-Oriented and Epidemiological Research</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Effects of Therapeutic Lifestyle Change diets high and low in dietary
fish-derived FAs on lipoprotein metabolism in middle-aged and elderly
subjects</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ooi</surname>
                    <given-names>Esther M. M.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">*</xref>
                  <xref ref-type="aff" rid="aff3">§</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lichtenstein</surname>
                    <given-names>Alice H.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">†</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Millar</surname>
                    <given-names>John S.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff4">**</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Diffenderfer</surname>
                    <given-names>Margaret R.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lamon-Fava</surname>
                    <given-names>Stefania</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rasmussen</surname>
                    <given-names>Helen</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Welty</surname>
                    <given-names>Francine K.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff5">††</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Barrett</surname>
                    <given-names>P. Hugh R.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff3">§</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Schaefer</surname>
                    <given-names>Ernst J.</given-names>
                  </name>
                  <xref ref-type="corresp" rid="cor1">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff1">*</xref>
                </contrib>
                <aff id="aff1"><label>*</label>Lipid Metabolism Laboratory, <institution>Jean
Mayer USDA Human Nutrition Research Center on Aging at Tufts
University</institution>, Boston, <addr-line>MA</addr-line> and</aff>
                <aff id="aff2"><label>†</label>Cardiovascular Nutrition Laboratory,
<institution>Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts
University</institution>, Boston, <addr-line>MA</addr-line></aff>
                <aff id="aff3"><label>§</label>Metabolic Research Centre, School of Medicine &amp;
Pharmacology and Faculty of Engineering, Computing and Mathematics,
<institution>University of Western Australia</institution>, Perth, Western
Australia, <country>Australia</country></aff>
                <aff id="aff4"><label>**</label>Institute for Translational Medicine and
Therapeutics, Institute for Diabetes, Obesity and Metabolism, <institution>University
of Pennsylvania</institution>, Philadelphia, <addr-line>PA</addr-line>; and</aff>
                <aff id="aff5"><label>††</label>Division of Cardiology, Beth Israel
Deaconess Medical Center, <institution>Harvard Medical School</institution>, Boston,
<addr-line>MA</addr-line></aff>
              </contrib-group>
              <author-notes>
                <corresp id="cor1"><label>1</label>To whom correspondence should be addressed. e-mail:
<email xlink:type="simple">Ernst.Schaefer@tufts.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub-ppub">
                <month>9</month>
                <year>2012</year>
              </pub-date>
              <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
              <pub-date pub-type="ppub">
                <month>9</month>
                <year>2012</year>
              </pub-date>
              <volume>53</volume>
              <issue>9</issue>
              <fpage>1958</fpage>
              <lpage>1967</lpage>
              <history>
                <date date-type="received">
                  <day>6</day>
                  <month>1</month>
                  <year>2012</year>
                </date>
                <date date-type="rev-recd">
                  <day>2</day>
                  <month>7</month>
                  <year>2012</year>
                </date>
              </history>
              <permissions>
                <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
                  <license-p><bold>Author's Choice</bold>—Final version full
access.</license-p>
                  <license-p><ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons
Attribution Non-Commercial License</ext-link> applies to Author Choice
Articles</license-p>
                </license>
              </permissions>
              <abstract>
                <p>The effects of Therapeutic Lifestyle Change (TLC) diets, low and high in dietary
fish, on apolipoprotein metabolism were examined. Subjects were provided with a
Western diet for 6 weeks, followed by 24 weeks of either of two TLC diets (10/group).
Apolipoprotein kinetics were determined in the fed state using stable isotope methods
and compartmental modeling at the end of each phase. Only the high-fish diet
decreased median triglyceride-rich lipoprotein (TRL) apoB-100 concentration
(−23%), production rate (PR, −9%), and direct catabolism (−53%),
and increased TRL-to-LDL apoB-100 conversion (+39%) as compared with the
baseline diet (all <italic>P</italic> &lt; 0.05). This diet also decreased TRL
apoB-48 concentration (−24%), fractional catabolic rate (FCR, −20%), and
PR (−50%) as compared with the baseline diet (all <italic>P</italic> &lt;
0.05). The high-fish and low-fish diets decreased LDL apoB-100 concentration
(−9%, −23%), increased LDL apoB-100 FCR (+44%, +48%), and
decreased HDL apoA-I concentration (−15%, −14%) and PR (−11%,
−12%) as compared with the baseline diet (all <italic>P</italic> &lt; 0.05). On
the high-fish diet, changes in TRL apoB-100 PR were negatively correlated with
changes in plasma eicosapentaenoic and docosahexaenoic acids. In conclusion, the
high-fish diet decreased TRL apoB-100 and TRL apoB-48 concentrations chiefly by
decreasing their PR. Both diets decreased LDL apoB-100 concentration by increasing
LDL apoB-100 FCR and decreased HDL apoA-I concentration by decreasing HDL apoA-I
PR.</p>
              </abstract>
              <kwd-group>
                <kwd>fatty acids</kwd>
                <kwd>hypercholesterolemia</kwd>
                <kwd>apolipoproteins</kwd>
                <kwd>dyslipidemias</kwd>
                <kwd>fish oil</kwd>
                <kwd>lipoproteins/linetics</kwd>
                <kwd>lipoproteins/metabolism</kwd>
                <kwd>nutrition</kwd>
                <kwd>omega-3 fatty acids</kwd>
                <kwd>mathematical modeling</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <p>Elevated LDL-cholesterol is an independent risk factor for coronary heart disease (CHD)
(<xref rid="bib1" ref-type="bibr">1</xref>). Nutritional and lifestyle modifications are
the cornerstone of both the National Cholesterol Education Program (NCEP) and the American
Heart Association (AHA) recommendations for the treatment of hyperlipidemia to prevent and
reduce the risk of CHD (<xref rid="bib2" ref-type="bibr">2</xref>, <xref rid="bib3" ref-type="bibr">3</xref>). Guidelines from both organizations have centered on reducing
saturated fat and cholesterol intakes. These recommendations have evolved over time, based
on epidemiological, clinical, and animal studies (<xref rid="bib4" ref-type="bibr">4</xref>–<xref rid="bib8" ref-type="bibr">8</xref>). The current dietary
recommendations for hypercholesterolemic subjects are to consume a diet consisting of 25%
to 35% of energy from fat, &lt;7% of energy from saturated fat, and &lt;200 mg cholesterol
per day (<xref rid="bib2" ref-type="bibr">2</xref>, <xref rid="bib3" ref-type="bibr">3</xref>). Of note, the consumption of diets consistent with the NCEP and AHA
recommendations have been shown to lower plasma total cholesterol and LDL-cholesterol
effectively, in the range of 14% to 20%, compared with diets commonly consumed within the
United States (<xref rid="bib8" ref-type="bibr">8</xref>–<xref rid="bib11" ref-type="bibr">11</xref>). An understanding of the mechanisms that confer these benefits
is, therefore, of clinical relevance.</p>
            <p>Beyond traditional macronutrients, dietary supplements may play a role in decreasing CHD
risk. Fish oils are a rich source of the long-chain n-3 FAs eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) (<xref rid="bib12" ref-type="bibr">12</xref>–<xref rid="bib14" ref-type="bibr">14</xref>). Epidemiological and intervention studies suggest
that fish oil consumption protects against CHD (<xref rid="bib12" ref-type="bibr">12</xref>–<xref rid="bib14" ref-type="bibr">14</xref>). Recent clinical outcome
trials with n-3 FAs reported mixed findings, however (<xref rid="bib15" ref-type="bibr">15</xref>–<xref rid="bib21" ref-type="bibr">21</xref>). In particular, the Alpha
Omega and the ORIGIN trials both failed to show a significant cardiovascular disease (CVD)
benefit (<xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib21" ref-type="bibr">21</xref>). It is noteworthy that in these trials, n-3 FAs were taken against a
background of optimal medical therapy for secondary prevention and the patients were at
high risk of CVD events. Whether similar results would have been observed at higher doses
of n-3 FAs and/or patients on suboptimal medical therapy is not known. Furthermore, the
exact significance of these findings to dietary recommendations to consume more fish is
unclear. Nonetheless, fish oils, provided as fish oil capsules, have been shown to decrease
plasma triglyceride and atherogenic triglyceride-rich lipoprotein (TRL) particle
concentrations by decreasing hepatic TRL apoB-100 synthesis and increasing TRL-to-LDL
apoB-100 conversion (<xref rid="bib22" ref-type="bibr">22</xref>–<xref rid="bib26" ref-type="bibr">26</xref>). The modification of lipid and lipoprotein
metabolism by fish oils appears to confer anti-atherogenic benefits (<xref rid="bib12" ref-type="bibr">12</xref>–<xref rid="bib14" ref-type="bibr">14</xref>).</p>
            <p>In the present study, we compared the effects of two diets adhering to the dietary
recommendations of the NCEP, one high and the other low in dietary fish-derived n-3 FAs, on
lipoprotein metabolism in middle-aged and elderly subjects under controlled isoenergetic
metabolic conditions. Of note, in the course of this work, the terminology changed from the
NCEP Step-2 diet to the Therapeutic Lifestyle Change (TLC) diet. Therefore, the designation
of TLC was applied. We hypothesized that the TLC diet high in dietary fish-derived n-3 FAs
would have a more favorable effect on lipoprotein metabolism compared with the TLC diet low
in dietary fish-derived n-3 FAs, chiefly by decreasing the production rates (PRs)of TRL
particles. Although we have previously reported the effects of these diets on plasma lipid
concentrations (<xref rid="bib9" ref-type="bibr">9</xref>–<xref rid="bib11" ref-type="bibr">11</xref>), the effects of these diets on apoB and apoA-I kinetics, however,
are novel.</p>
            <sec sec-type="methods">
              <title>METHODS</title>
              <sec>
                <title>Subjects</title>
                <p>Twenty subjects (7 men and 13 women) aged &gt;40 years participated in this study.
All women were postmenopausal. Subjects had no evidence of any chronic illness
including endocrine, hepatic, renal, thyroid, or cardiac dysfunction, and were not
taking any medications known to affect lipid metabolism. All were nonsmokers and
consumed no alcohol during the study. The study protocol was approved by the Tufts
University Human Investigation Review Committee. All subjects provided written
consent. The study was completed prior to the development of the <ext-link ext-link-type="uri" xlink:href="clinicaltrials.gov">clinicaltrials.gov</ext-link> registry.</p>
              </sec>
              <sec>
                <title>Study design and clinical protocols</title>
                <p>The compositions of the diets are shown in <xref ref-type="table" rid="tbl1"><bold>Table 1</bold></xref>. The nutritional composition of the diets was
determined by food analysis at the Hazelton Laboratories (Madison, WI), except for
the individual type of PUFAs, which were calculated using food com­position
tables (GRAND database, release 867; USDA Human Nutrition Research Center, Grand
Forks, ND) (<xref rid="bib9" ref-type="bibr">9</xref>–<xref rid="bib11" ref-type="bibr">11</xref>). The 20 subjects consumed a diet approximating that of a
Western-type diet (35% of energy as total fat, 14% of energy as saturated fat, 35 mg
cholesterol/MJ) as the baseline diet for 6 weeks. Ten subjects were then assigned to
receive the TLC diet high in fish (TLC high-fish), while the remaining 10, the TLC
diet low in fish and high in poultry (TLC low-fish) for 24 weeks. The two TLC diets
were similar in composition (&lt;30% of energy as total fat, &lt;7% of energy as
saturated fat, ≤15 mg cholesterol/MJ), differing primarily in the content of
fish-derived n-3 FAs (TLC high-fish: 0.70% calories or 1.23 g/day in EPA and DHA
equivalent to fish served 8 times per week vs TLC low-fish: 0.13% calories or 0.27
g/day in EPA and DHA equivalent to fish served twice per week). Of note, the types of
fish provided were sole fillet, salmon, and tuna. The difference in energy derived
from total fat between the baseline diet and the TLC diets was compensated for by an
increase in energy derived primarily from complex carbohydrate (<xref rid="bib9" ref-type="bibr">9</xref>–<xref rid="bib11" ref-type="bibr">11</xref>). All meals
(breakfast, lunch, dinner, after-lunch snack, and after-dinner snack) were prepared
by the Metabolic Research Unit Kitchen of the Jean Mayer U.S. Department of
Agriculture Human Nutrition Research Center on Aging at Tufts University. Energy
intake was adjusted to maintain body weight. Subjects were allowed to eat and drink
only items provided by the Center, except for water and noncaloric beverages.
Subjects were advised to maintain a constant level of physical activity.</p>
                <table-wrap id="tbl1" position="float">
                  <label>TABLE 1.</label>
                  <caption>
                    <p>Composition of the baseline and TLC diets, as assessed by chemical analysis of
food<xref ref-type="table-fn" rid="tblfn1"><italic><sup>a</sup></italic></xref></p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">Baseline</td>
                        <td align="center" rowspan="1" colspan="1">High-Fish Diet</td>
                        <td align="center" rowspan="1" colspan="1">Low-Fish Diet</td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td rowspan="1" colspan="1">(% of energy)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Carbohydrate</td>
                        <td align="center" rowspan="1" colspan="1">49.4 ± 2.2</td>
                        <td align="center" rowspan="1" colspan="1">56.1 ± 2.9</td>
                        <td align="center" rowspan="1" colspan="1">58.2 ± 1.8</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Protein</td>
                        <td align="center" rowspan="1" colspan="1">15.0 ± 1.2</td>
                        <td align="center" rowspan="1" colspan="1">17.2 ± 0.9</td>
                        <td align="center" rowspan="1" colspan="1">16.3 ± 0.7</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Fat</td>
                        <td align="center" rowspan="1" colspan="1">35.4 ± 2.3</td>
                        <td align="center" rowspan="1" colspan="1">26.4 ± 2.0</td>
                        <td align="center" rowspan="1" colspan="1">25.5 ± 1.8</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Saturated FAs</td>
                        <td align="center" rowspan="1" colspan="1">14.1 ± 2.2</td>
                        <td align="center" rowspan="1" colspan="1">4.5 ± 0.7</td>
                        <td align="center" rowspan="1" colspan="1">4.0 ± 0.4</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">14:0</td>
                        <td align="center" rowspan="1" colspan="1">1.6 ± 0.3</td>
                        <td align="center" rowspan="1" colspan="1">0.2 ± 0.1</td>
                        <td align="center" rowspan="1" colspan="1">0.1 ± 0.0</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">16:0</td>
                        <td align="center" rowspan="1" colspan="1">7.1 ± 0.5</td>
                        <td align="center" rowspan="1" colspan="1">2.9 ± 0.6</td>
                        <td align="center" rowspan="1" colspan="1">2.2 ± 0.3</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">18:0</td>
                        <td align="center" rowspan="1" colspan="1">2.9 ± 0.2</td>
                        <td align="center" rowspan="1" colspan="1">1.3 ± 0.4</td>
                        <td align="center" rowspan="1" colspan="1">1.0 ± 0.1</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Monounsaturated FAs</td>
                        <td align="center" rowspan="1" colspan="1">14.5 ± 1.0</td>
                        <td align="center" rowspan="1" colspan="1">11.6 ± 1.4</td>
                        <td align="center" rowspan="1" colspan="1">10.8 ± 0.9</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">18:1n-9</td>
                        <td align="center" rowspan="1" colspan="1">12.6 ± 1.1</td>
                        <td align="center" rowspan="1" colspan="1">10.5 ± 2.2</td>
                        <td align="center" rowspan="1" colspan="1">10.7 ± 2.7</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Polyunsaturated FAs</td>
                        <td align="center" rowspan="1" colspan="1">6.9 ± 1.2</td>
                        <td align="center" rowspan="1" colspan="1">10.3 ± 0.2</td>
                        <td align="center" rowspan="1" colspan="1">10.5 ± 0.2</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">18:2n-6<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">4.1 ± 0.2</td>
                        <td align="center" rowspan="1" colspan="1">7.0 ± 0.4</td>
                        <td align="center" rowspan="1" colspan="1">7.1 ± 0.8</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">18:3n-3<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">0.7 ± 0.2</td>
                        <td align="center" rowspan="1" colspan="1">1.9 ± 0.6</td>
                        <td align="center" rowspan="1" colspan="1">2.0 ± 0.2</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">20:4n-6<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td align="center" rowspan="1" colspan="1">0.1 ± 0.1</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.02</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">20:5n-3<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td align="center" rowspan="1" colspan="1">0.2 ± 0.1</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.02</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">22:6n-3<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td align="center" rowspan="1" colspan="1">0.5 ± 0.1</td>
                        <td align="center" rowspan="1" colspan="1">0.1 ± 0.1</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Cholesterol (mg/MJ)</td>
                        <td align="center" rowspan="1" colspan="1">35 ± 6</td>
                        <td align="center" rowspan="1" colspan="1">15 ± 4</td>
                        <td align="center" rowspan="1" colspan="1">11 ± 4</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="tblfn1">
                      <label>a</label>
                      <p>Data are presented as mean ± SD of triplicate samples.</p>
                    </fn>
                    <fn id="tblfn2">
                      <label>b</label>
                      <p>Values are derived from food composition table.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>At the end of each diet phase, a primed, constant infusion of deuterated-leucine
(5,5,5-<sup>2</sup>H<sub>3</sub>-<sc>l</sc>-leucine; Cambridge Isotope
Laboratories, Andover, MA) was administered intravenously in the fed state to
determine the kinetics of apolipoproteins, as previously described (<xref rid="bib9" ref-type="bibr">9</xref>, <xref rid="bib27" ref-type="bibr">27</xref>,
<xref rid="bib28" ref-type="bibr">28</xref>). In brief, following a 12 h overnight
fast, subjects were provided with the experimental meal on an hourly basis for 20 h.
The amount of food provided at each hour was 5% of the daily energy intake. The
composition of the portioned meal approximated that of the diet that was provided
prior to the infusion period. Five hours after the first meal, a bolus dose of
deuterated leucine (10 µmol/kg) was administered, followed by a 15 h infusion
of deuterated leucine (10 µmol/kg/hour). Blood samples were collected prior to
the isotope infusion (time = 0 minute) and at 1, 2, 3, 4, 6, 8, 10, 12, and 15
h during the infusion.</p>
              </sec>
              <sec>
                <title>Laboratory analyses</title>
                <p>The protocol for plasma lipid and lipoprotein characterization, quantification, and
isolation of the apolipoproteins, isotopic enrichment determinations, and kinetic
analysis were performed as previously described (<xref rid="bib28" ref-type="bibr">28</xref>, <xref rid="bib29" ref-type="bibr">29</xref>, <xref rid="bib30" ref-type="bibr">30</xref>). Plasma samples were stored at −80°C, and all
laboratory analyses were completed within 1 year after each diet phase. In brief,
fasting lipid and apolipoprotein values were averages of the blood samples collected
at weeks 4, 5, and 6 for the baseline diet, and weeks 4, 8, 16, and 24 for the TLC
diets. Nonfasting lipid and apolipoprotein values were averages of blood samples
collected at 1, 4, 8, 12, and 15 h during the infusion study. ApoB within plasma,
TRL, and IDL were measured using a noncompetitive ELISA (<xref rid="bib31" ref-type="bibr">31</xref>). The proportion of apoB within the TRL fraction that was
apoB-100 and apoB-48 was determined by densitometric scanning of Coomassie-stained
gels (<xref rid="bib31" ref-type="bibr">31</xref>, <xref rid="bib32" ref-type="bibr">32</xref>). Plasma apoA-I concentration was measured using an immunoturbidimetric
assay, reagents, and calibrators from Wako Diagnostics (Richmond, VA).</p>
                <p>Fasting plasma FA composition during different diets was measured as previously
described (<xref rid="bib33" ref-type="bibr">33</xref>, <xref rid="bib34" ref-type="bibr">34</xref>). In brief, FAs from lipid extracts of plasma were
methyl-esterified and analyzed on a 5890 gas-liquid chromatograph (Hewlett-Packard;
Palo Alto, CA) fitted with a 105 m fused silica capillary column, liquid-phase RTX
2330 (Restek Corp.; Port Matilda, PA) and a flame-ionization detector. Peak
identification was obtained by chromatography of known FA methyl esters. Data were
normalized by comparing the area of the FA peak with the area of the internal
standard peak, heptadecanoic acid. The FA composition is expressed as a percentage of
the total area of the identified FA peaks.</p>
              </sec>
              <sec>
                <title>Kinetic analyses</title>
                <p>A multi-compartmental model (<xref ref-type="fig" rid="fig1"><bold>Fig.
1A</bold></xref>) was used to describe TRL-, IDL- and LDL apoB-100 kinetics. The
SAAM II program (University of Washington, Seattle, WA) was used for modeling the
data. The details and assumptions of the model have been described previously (<xref rid="bib29" ref-type="bibr">29</xref>, <xref rid="bib30" ref-type="bibr">30</xref>). The model consists of seven compartments. Compartment 1 represents the
precursor compartment, the plasma leucine pool. Compartment 2 is an intracellular
delay compartment that accounts for the synthesis and secretion of apoB-100 into the
TRL pool (compartment 3). Compartments 3 and 4 account for the kinetics of apoB-100
in the TRL fraction. Compartment 5 accounts for the kinetics of IDL apoB-100. The
kinetics of LDL apoB-100 are described by a plasma compartment (compartment 7). In
order to fit the LDL apoB-100 tra­cer data, a delay compartment (compartment 6)
between the TRL (compartment 3) and LDL compartments was required. The presence of a
delay between TRL- and LDL apoB-100 has been previously reported, with studies
suggesting that VLDL may leave plasma and reappear later in LDL (<xref rid="bib35" ref-type="bibr">35</xref>, <xref rid="bib36" ref-type="bibr">36</xref>). The delay time for compartment 6 was (mean ± SEM) 0.40 ±
0.08 h for the TLC high-fish diet group and 0.46 ± 0.10 h for the TLC low-fish
group. There was no significant difference in the delay time between the diet groups
at baseline. No significant effect of diet on this delay time was observed.</p>
                <fig id="fig1" position="float">
                  <label>Fig. 1.</label>
                  <caption>
                    <p>A: Compartment model describing TRL, IDL and LDL apoB-100 kinetics The apoB-100
model consisted of seven compartments. Compartment 1 represents the precursor
compartment, the plasma leucine pool. Compartment 2 is an intracellular delay
compartment that accounts for the synthesis and secretion of apoB-100 into the
TRL pool (compartment 3). Compartments 3 and 4 account for the kinetics of
apoB-100 in the TRL fraction. Compartment 5 accounts for the kinetics of IDL
apoB-100. The kinetics of LDL apoB-100 are described by a plasma compartment
(compartment 7). In order to fit the LDL apoB-100 tracer data, a delay
compartment (compartment 6) between the TRL and LDL compartments was required.
B: Compartment model describing TRL apoB-48 and HDL apoA-I kinetics The
kinetics of TRL apoB-48 and HDL apoA-I were described by a three-compartment
model. Compartment 1 represents the precursor compartment, which is the plasma
leucine pool. Compartment 2 is an intracellular delay compartment that accounts
for the synthesis and secretion of apoB-48 or apoA-I into the TRL or the HDL
pool, respectively (compartment 3). Compartment 3 accounts for the kinetics of
apoB-48 or apoA-I in the TRL or HDL fraction, respectively. Of note, the TRL
apoB-100 plateau was used as the tracer plateau for HDL apoA-I kinetic
analysis.</p>
                  </caption>
                  <graphic xlink:href="1958fig1"/>
                </fig>
                <p>The kinetics of TRL apoB-48 and HDL apoA-I were described by a three-compartment
model (<xref ref-type="fig" rid="fig1">Fig. 1B</xref>). Compartment 1 represents the
precursor compartment, the plasma leucine pool. Compartment 2 is an intracellular
delay compartment that accounts for the synthesis and secretion of apoB-48 or apoA-I
into the TRL or the HDL pool, respectively (compartment 3). Compartment 3 accounts
for the kinetics of apoB-48 or apoA-I in the TRL or HDL fraction, respectively. Of
note, the TRL apoB-100 plateau was used as the tracer plateau for HDL apoA-I kinetic
analysis.</p>
                <p>The fractional catabolic rates (FCRs) of TRL, IDL, and LDL apoB-100, TRL apoB-48, and
HDL apoA-I were derived from the model parameters giving the best fit. The
corresponding PRs were calculated as the product of FCR and pool size, which equals
the plasma concentration multiplied by plasma volume estimated as 4.5% of body weight
in kilograms.</p>
              </sec>
              <sec>
                <title>Statistical analyses</title>
                <p>Statistical analyses were performed using STATA (Version 11.1; StataCorp, College
Station, TX). Data are presented as medians and inter-quartile ranges to account for
the skewed nature of the parameters. Baseline values were different between the diet
groups. As such, the change from baseline (change score) was used in all analyses to
account for these differences. The change from baseline value of each variable was
defined as the value of the variable on the TLC diet (high-fish or low-fish diets)
minus the value of that same variable on the corresponding baseline diet. Wilcoxon
signed-rank tests were performed to test for difference between each TLC diet group
and their corresponding baseline diet. Mann-Whitney tests were performed to test for
difference in the change from baseline in variables between the TLC high-fish diet
and the TLC low-fish diet. Spearman correlation coefficients were determined to
examine the statistical associations between changes from baseline in variables. The
<italic>P</italic> values are reported, with statistical significance set at the
5% level.</p>
              </sec>
            </sec>
            <sec sec-type="results">
              <title>RESULTS</title>
              <p>The two groups of subjects (TLC high-fish vs. TLC low-fish) were similar with respect to
age [67 (60–70) vs<italic>.</italic> 66 (44–71) years] and body mass index
[26.0 (22.7–28.0) vs<italic>.</italic> 24.7 (23.5–28.8) kg/m<sup>2</sup>],
and had, on average, mild to moderate hypercholesterolemia [fasting lipids and
lipoprotein: total cholesterol, 5.16 (4.78–6.26) vs<italic>.</italic> 5.47
(4.81–6.81) mmol/l and LDL cholesterol: 3.37 (3.03–4.51)
vs<italic>.</italic> 3.46 (3.25–4.70) mmol/l]. The TLC high-fish diet group
consisted of four men and six women, whereas the TLC low-fish group, three men and seven
women. No significant changes in body weight were observed in either TLC diet group
compared with the baseline diet.</p>
              <sec>
                <title>Effects on fasting plasma FA profile</title>
                <p>The effects of the TLC diets on fasting plasma FA profile in the subjects are shown
in <xref ref-type="table" rid="tbl2"><bold>Table 2</bold></xref>. The decreases in
oleic (18:1n-9) and arachidonic (20:4n-6) acids were significantly greater with the
TLC high-fish compared with the low-fish diet (<italic>P</italic> &lt; 0.02 and
<italic>P</italic> = 0.02, respectively). The increases in EPA (20:5n-3)
and DHA (22:6n-3) were, on average, 1.6- and 1.3-fold higher with the TLC high-fish
diet compared with the TLC low-fish diet, respectively (<italic>P</italic> &lt; 0.01
for both). Both TLC diets reduced saturated FAs (14:0, 16:0, and 18:0) and increased
α-linolenic acid (18:3n-3) by a similar magnitude.</p>
                <table-wrap id="tbl2" position="float">
                  <label>TABLE 2.</label>
                  <caption>
                    <p>Fasting plasma FA profile of study subjects following baseline, TLC high-fish,
and TLC low-fish diets</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td rowspan="1" colspan="1">FAs (mol %)</td>
                        <td align="center" rowspan="1" colspan="1">Baseline Diet</td>
                        <td align="center" rowspan="1" colspan="1">High-Fish Diet</td>
                        <td align="center" rowspan="1" colspan="1">Median % Change from Baseline Diet</td>
                        <td align="center" rowspan="1" colspan="1">Baseline Diet</td>
                        <td align="center" rowspan="1" colspan="1">Low-Fish Diet</td>
                        <td align="center" rowspan="1" colspan="1">Median % Change from Baseline Diet</td>
                        <td align="center" rowspan="1" colspan="1">High-Fish Diet vs. Low-Fish Diet <xref ref-type="table-fn" rid="tblfn3"><italic><sup>a</sup></italic></xref><italic>P</italic></td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td rowspan="1" colspan="1">14:00</td>
                        <td align="char" char="." rowspan="1" colspan="1">1.00 (0.79, 1.54)</td>
                        <td align="center" rowspan="1" colspan="1">0.75 (0.71, 1.08)<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−23</td>
                        <td align="center" rowspan="1" colspan="1">0.86 (0.72, 0.98)</td>
                        <td align="center" rowspan="1" colspan="1">0.65 (0.59, 0.95)<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−18</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.41</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">16:00</td>
                        <td align="center" rowspan="1" colspan="1">20.0 (19.3, 21.8)</td>
                        <td align="center" rowspan="1" colspan="1">18.8 (18.2, 20.3)<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−6</td>
                        <td align="center" rowspan="1" colspan="1">20.3 (18.8, 22.1)</td>
                        <td align="center" rowspan="1" colspan="1">18.9 (16.5, 21.3)</td>
                        <td align="center" rowspan="1" colspan="1">−5</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.62</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">18:00</td>
                        <td align="center" rowspan="1" colspan="1">6.33 (6.19, 6.77)</td>
                        <td align="center" rowspan="1" colspan="1">6.18 (5.94, 6.27)<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−5</td>
                        <td align="center" rowspan="1" colspan="1">6.28 (5.86, 7.55)</td>
                        <td align="center" rowspan="1" colspan="1">6.10 (5.37, 7.25)<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−6</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.22</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">18:1n-9</td>
                        <td align="center" rowspan="1" colspan="1">17.3 (16.1, 18.6)</td>
                        <td align="center" rowspan="1" colspan="1">15.0 (13.8, 16:1)<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−13</td>
                        <td align="center" rowspan="1" colspan="1">18.3 (16.7, 19.3)</td>
                        <td align="center" rowspan="1" colspan="1">18.9 (17.5, 20.4)</td>
                        <td align="char" char="." rowspan="1" colspan="1">5</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.01</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">18:2n-6</td>
                        <td align="center" rowspan="1" colspan="1">32.0 (27.6, 33.9)</td>
                        <td align="center" rowspan="1" colspan="1">34.4 (29.9, 35.8)</td>
                        <td align="char" char="." rowspan="1" colspan="1">7</td>
                        <td align="center" rowspan="1" colspan="1">36.9 (30.2, 40.8)</td>
                        <td align="center" rowspan="1" colspan="1">36.7 (32.3, 43.6)</td>
                        <td align="char" char="." rowspan="1" colspan="1">2</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.12</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">18:3n-3</td>
                        <td align="center" rowspan="1" colspan="1">0.57 (0.52, 0.81)</td>
                        <td align="center" rowspan="1" colspan="1">1.17 (1.04, 1.22)<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td>
                        <td align="char" char="." rowspan="1" colspan="1">106</td>
                        <td align="center" rowspan="1" colspan="1">0.47 (0.39, 0.65)</td>
                        <td align="center" rowspan="1" colspan="1">1.03 (0.47, 1.38)<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td>
                        <td align="char" char="." rowspan="1" colspan="1">106</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.57</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">20:4n-6</td>
                        <td align="center" rowspan="1" colspan="1">7.87 (7.13, 8.53)</td>
                        <td align="center" rowspan="1" colspan="1">5.92 (5.43, 6.51)<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−28</td>
                        <td align="center" rowspan="1" colspan="1">8.37 (7.70, 8.94)</td>
                        <td align="center" rowspan="1" colspan="1">7.17 (5.39, 7.90)<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−17</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.02</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">20:5n-3</td>
                        <td align="center" rowspan="1" colspan="1">0.67 (0.55, 0.77)</td>
                        <td align="center" rowspan="1" colspan="1">2.72 (1.82, 3.39)<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td>
                        <td align="char" char="." rowspan="1" colspan="1">287</td>
                        <td align="center" rowspan="1" colspan="1">0.47 (0.42, 0.62)</td>
                        <td align="center" rowspan="1" colspan="1">0.75 (0.56, 0.92)<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td>
                        <td align="char" char="." rowspan="1" colspan="1">53</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.01</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">22:6n-3</td>
                        <td align="center" rowspan="1" colspan="1">2.97 (2.35, 3.70)</td>
                        <td align="center" rowspan="1" colspan="1">5.15 (4.15, 6.23)<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td>
                        <td align="char" char="." rowspan="1" colspan="1">65</td>
                        <td align="center" rowspan="1" colspan="1">1.74 (1.70, 2.30)</td>
                        <td align="center" rowspan="1" colspan="1">2.09 (1.84, 2.54)<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td>
                        <td align="char" char="." rowspan="1" colspan="1">10</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.01</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn>
                      <p>Data are presented as median (IQR).</p>
                    </fn>
                    <fn id="tblfn3">
                      <label>a</label>
                      <p>Comparison between change from baseline of high-fish vs. low-fish diet. n
= 10.</p>
                    </fn>
                    <fn id="tblfn4">
                      <label>b</label>
                      <p><italic>P</italic> &lt; 0.05 compared with corresponding baseline diet.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec>
                <title>Effects on plasma lipids and apolipoproteins</title>
                <p>The effects of the two TLC diets on nonfasting plasma lipoprotein and apolipoprotein
concentrations are shown in <xref ref-type="table" rid="tbl3"><bold>Table
3</bold></xref>. There was a 24% decrease in plasma triglycerides with the TLC
high-fish diet compared with a 1% decrease with the TLC low-fish diet
(<italic>P</italic> = 0.02). Although both diets decreased HDL cholesterol
concentration, the decrease was significantly less in the TLC high-fish compared with
the TLC low-fish diet (<italic>P</italic> = 0.04). Both TLC diets had
comparable effects on total cholesterol, LDL cholesterol and plasma apoB and apoA-I
concentrations.</p>
                <table-wrap id="tbl3" position="float">
                  <label>TABLE 3.</label>
                  <caption>
                    <p>Postprandial plasma lipid, lipoprotein, and apolipoprotein concentrations
following baseline, TLC high-fish, and TLC low-fish diets</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">Baseline Diet</td>
                        <td align="center" rowspan="1" colspan="1">High-Fish Diet</td>
                        <td align="center" rowspan="1" colspan="1">Median % Change from Baseline Diet</td>
                        <td align="center" rowspan="1" colspan="1">Baseline Diet</td>
                        <td align="center" rowspan="1" colspan="1">Low-Fish Diet</td>
                        <td align="center" rowspan="1" colspan="1">Median % Change from Baseline Diet</td>
                        <td align="center" rowspan="1" colspan="1">High-Fish vs. Low-Fish<xref ref-type="table-fn" rid="tblfn5"><italic><sup>a</sup></italic></xref><italic>P</italic></td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td rowspan="1" colspan="1">Total cholesterol,  mmol/l</td>
                        <td align="center" rowspan="1" colspan="1">4.77 (4.29, 5.88)</td>
                        <td align="center" rowspan="1" colspan="1">3.99 (3.72, 5.02)<xref ref-type="table-fn" rid="tblfn6"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−16</td>
                        <td align="center" rowspan="1" colspan="1">5.02 (4.39, 6.24)</td>
                        <td align="center" rowspan="1" colspan="1">3.97 (3.50, 4.96)<xref ref-type="table-fn" rid="tblfn6"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−19</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.26</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Triglyceride, mmol/l</td>
                        <td align="center" rowspan="1" colspan="1">1.93 (1.51, 2.87)</td>
                        <td align="center" rowspan="1" colspan="1">1.46 (1.21, 1.79)<xref ref-type="table-fn" rid="tblfn6"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−24</td>
                        <td align="center" rowspan="1" colspan="1">1.56 (1.38, 2.34)</td>
                        <td align="center" rowspan="1" colspan="1">1.76 (1.30, 2.07)</td>
                        <td align="center" rowspan="1" colspan="1">−1</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.02</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">LDL cholesterol,  mmol/l</td>
                        <td align="center" rowspan="1" colspan="1">3.24 (2.97, 3.71)</td>
                        <td align="center" rowspan="1" colspan="1">2.50 (2.08, 2.88)<xref ref-type="table-fn" rid="tblfn6"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−22</td>
                        <td align="center" rowspan="1" colspan="1">3.48 (3.11, 4.32)</td>
                        <td align="center" rowspan="1" colspan="1">2.70 (2.31, 3.34)<xref ref-type="table-fn" rid="tblfn6"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−24</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.82</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">HDL cholesterol,  mmol/l</td>
                        <td align="center" rowspan="1" colspan="1">1.16 (0.83, 1.48)</td>
                        <td align="center" rowspan="1" colspan="1">1.04 (0.71, 1.52)</td>
                        <td align="center" rowspan="1" colspan="1">−9</td>
                        <td align="center" rowspan="1" colspan="1">1.06 (0.93, 1.31)</td>
                        <td align="center" rowspan="1" colspan="1">0.93 (0.71, 1.06)<xref ref-type="table-fn" rid="tblfn6"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−19</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.04</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Apolipoprotein B, g/l</td>
                        <td align="center" rowspan="1" colspan="1">0.97 (0.92, 1.15)</td>
                        <td align="center" rowspan="1" colspan="1">0.82 (0.79, 0.97)<xref ref-type="table-fn" rid="tblfn6"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−14</td>
                        <td align="center" rowspan="1" colspan="1">1.12 (0.99, 1.40)</td>
                        <td align="center" rowspan="1" colspan="1">0.98 (0.73, 1.21)<xref ref-type="table-fn" rid="tblfn6"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−20</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.11</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Apolipoprotein A-I, g/l</td>
                        <td align="center" rowspan="1" colspan="1">1.24 (1.09, 1.39)</td>
                        <td align="center" rowspan="1" colspan="1">1.04 (0.92, 1.14)<xref ref-type="table-fn" rid="tblfn6"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−18</td>
                        <td align="center" rowspan="1" colspan="1">1.29 (1.14, 1.48)</td>
                        <td align="center" rowspan="1" colspan="1">1.08 (0.93, 1.27)<xref ref-type="table-fn" rid="tblfn6"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−21</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.94</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn>
                      <p>Data are presented as median (IQR).</p>
                    </fn>
                    <fn id="tblfn5">
                      <label>a</label>
                      <p><italic>P</italic> &lt; 0.05 compared with corresponding baseline diet. To
convert cholesterol, HDL cholesterol, LDL cholesterol and non-HDL
cholesterol in mmol/l to mg/dl, divide by 0.0259; triglycerides in mmol/l to
mg/dl, divide by 0.0113.</p>
                    </fn>
                    <fn id="tblfn6">
                      <label>b</label>
                      <p>Comparison between change from baseline of high-fish vs. low-fish diet, n
= 10.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec>
                <title>Effects on TRL, IDL, and LDL apoB-100 metabolism</title>
                <p>The effects of the TLC diets on TRL, IDL, and LDL apoB-100 concentrations and
kinetics are shown in <xref ref-type="table" rid="tbl4"><bold>Table 4</bold></xref>.
There was a 23% decrease in TRL apoB-100 concentration with the TLC high-fish diet
compared with a 1% increase with the TLC low-fish diet (<italic>P</italic> &lt;
0.01). TRL apoB-100 PR was significantly decreased by 9% with the TLC high-fish diet
as compared with a 1% increase with the TLC low-fish diet (<italic>P</italic>
= 0.03). The direct catabolism of TRL apoB-100 was significantly decreased by
53% with the TLC high-fish diet compared with the 3% increase with the TLC low-fish
diet (<italic>P</italic> &lt; 0.01). Although both diets decreased LDL apoB-100
concentration, the decrease was significantly less with the TLC high-fish diet
compared with the TLC low-fish diet (<italic>P</italic> = 0.01). There was a
39% increase in TRL-to-LDL apoB-100 conversion with the TLC high-fish diet compared
with a 7% increase with the TLC low-fish diet, but this failed to reach statistical
significance (<italic>P</italic> = 0.08). Both diets had comparable effects on
IDL and LDL apoB-100 FCR and PR, and the conversion of TRL-to-IDL apoB-100 and
IDL-to-LDL apoB-100.</p>
                <table-wrap id="tbl4" position="float">
                  <label>TABLE 4.</label>
                  <caption>
                    <p>Concentrations and kinetics of TRL, IDL and LDL apoB-100, TRL apoB-48, and HDL
apoA-I following baseline, TLC high-fish, and TLC low-fish diets</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">Baseline Diet</td>
                        <td align="center" rowspan="1" colspan="1">High-Fish Diet (HF)</td>
                        <td align="center" rowspan="1" colspan="1">Median % Change from Baseline Diet</td>
                        <td align="center" rowspan="1" colspan="1">Baseline Diet</td>
                        <td align="center" rowspan="1" colspan="1">Low-Fish Diet</td>
                        <td align="center" rowspan="1" colspan="1">Median % Change from Baseline Diet</td>
                        <td align="center" rowspan="1" colspan="1">High Fat vs. Low Fat <xref ref-type="table-fn" rid="tblfn7"><italic><sup>a</sup></italic></xref><italic>P</italic></td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td colspan="8" rowspan="1">Concentrations (mg/l)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> TRL apoB-100</td>
                        <td align="center" rowspan="1" colspan="1">9.57 (5.26, 16.3)</td>
                        <td align="center" rowspan="1" colspan="1">6.58 (4.12, 40.4)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−23</td>
                        <td align="center" rowspan="1" colspan="1">5.52 (3.53, 8.63)</td>
                        <td align="center" rowspan="1" colspan="1">5.63 (3.32, 8.10)</td>
                        <td align="char" char="." rowspan="1" colspan="1">1</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.01</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> IDL apoB-100</td>
                        <td align="center" rowspan="1" colspan="1">2.27 (1.03, 2.45)</td>
                        <td align="center" rowspan="1" colspan="1">1.77 (1.44, 2.19)</td>
                        <td align="center" rowspan="1" colspan="1">−3</td>
                        <td align="center" rowspan="1" colspan="1">1.59 (0.88, 3.21)</td>
                        <td align="center" rowspan="1" colspan="1">1.3 (1.00, 2.66)</td>
                        <td align="center" rowspan="1" colspan="1">−17</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.97</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> LDL apoB-100</td>
                        <td align="center" rowspan="1" colspan="1">85.1 (75.9, 96.7)</td>
                        <td align="center" rowspan="1" colspan="1">73.0 (67.6, 91.1)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−9</td>
                        <td align="center" rowspan="1" colspan="1">105 (91.9, 133)</td>
                        <td align="center" rowspan="1" colspan="1">90.3 (67.1, 111)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−23</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.01</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> TRL apoB-48</td>
                        <td align="center" rowspan="1" colspan="1">0.48 (0.31, 0.9)</td>
                        <td align="center" rowspan="1" colspan="1">0.42 (0.10, 0.56)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−24</td>
                        <td align="center" rowspan="1" colspan="1">0.33 (0.31, 0.71)</td>
                        <td align="center" rowspan="1" colspan="1">0.34 (0.27, 0.79)</td>
                        <td align="char" char="." rowspan="1" colspan="1">6</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.04</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> HDL apoA-I</td>
                        <td align="center" rowspan="1" colspan="1">120 (109, 139)</td>
                        <td align="center" rowspan="1" colspan="1">104 (92, 114)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−15</td>
                        <td align="center" rowspan="1" colspan="1">129 (114, 148)</td>
                        <td align="center" rowspan="1" colspan="1">108 (93, 127)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−14</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.77</td>
                      </tr>
                      <tr>
                        <td colspan="2" rowspan="1">Fractional catabolic rates (pools/day)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> TRL apoB-100</td>
                        <td align="center" rowspan="1" colspan="1">5.91 (4.18, 8.89)</td>
                        <td align="center" rowspan="1" colspan="1">8.22 (5.44, 10.8)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="char" char="." rowspan="1" colspan="1">16</td>
                        <td align="center" rowspan="1" colspan="1">7.71 (5.04, 11.5)</td>
                        <td align="center" rowspan="1" colspan="1">7.1 (4.84, 16.3)</td>
                        <td align="center" rowspan="1" colspan="1">−9</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.50</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> IDL apoB-100</td>
                        <td align="center" rowspan="1" colspan="1">2.92 (2.12, 3.39)</td>
                        <td align="center" rowspan="1" colspan="1">3.79 (2.62, 5.27)</td>
                        <td align="char" char="." rowspan="1" colspan="1">37</td>
                        <td align="center" rowspan="1" colspan="1">2.93 (1.93, 5.64)</td>
                        <td align="center" rowspan="1" colspan="1">3.82 (2.45, 5.50)</td>
                        <td align="char" char="." rowspan="1" colspan="1">12</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.50</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> LDL apoB-100</td>
                        <td align="center" rowspan="1" colspan="1">0.25 (0.22, 0.38)</td>
                        <td align="center" rowspan="1" colspan="1">0.43 (0.32, 0.46)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="char" char="." rowspan="1" colspan="1">44</td>
                        <td align="center" rowspan="1" colspan="1">0.28 (0.22, 0.36)</td>
                        <td align="center" rowspan="1" colspan="1">0.43 (0.35, 0.54)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="char" char="." rowspan="1" colspan="1">48</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.76</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> TRL apoB-48</td>
                        <td align="center" rowspan="1" colspan="1">4.93 (3.69, 5.79)</td>
                        <td align="center" rowspan="1" colspan="1">3.37 (2.73 . 5.24)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−20</td>
                        <td align="center" rowspan="1" colspan="1">4.58 (2.78, 5.10)</td>
                        <td align="center" rowspan="1" colspan="1">3.71 (3.02, 5.14)</td>
                        <td align="char" char="." rowspan="1" colspan="1">8</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.04</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> HDL apoA-I</td>
                        <td align="center" rowspan="1" colspan="1">0.21 (0.19, 0.26)</td>
                        <td align="center" rowspan="1" colspan="1">0.22 (0.18, 0.27)</td>
                        <td align="char" char="." rowspan="1" colspan="1">9</td>
                        <td align="center" rowspan="1" colspan="1">0.22 (0.18, 0.27)</td>
                        <td align="center" rowspan="1" colspan="1">0.21 (0.18, 0.26)</td>
                        <td align="char" char="." rowspan="1" colspan="1">2</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.97</td>
                      </tr>
                      <tr>
                        <td colspan="2" rowspan="1">Production rates (mg/kg/day)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> TRL apoB-100</td>
                        <td align="center" rowspan="1" colspan="1">28.2 (20.4, 34.3)</td>
                        <td align="center" rowspan="1" colspan="1">23.2 (18.1, 27.1)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−9</td>
                        <td align="center" rowspan="1" colspan="1">22 (14.9, 23.2)</td>
                        <td align="center" rowspan="1" colspan="1">22.9 (16.0, 26.5)</td>
                        <td align="char" char="." rowspan="1" colspan="1">1</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.03</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> IDL apoB-100</td>
                        <td align="center" rowspan="1" colspan="1">3.41 (1.07, 3.63)</td>
                        <td align="center" rowspan="1" colspan="1">2.75 (1.99, 4.00)</td>
                        <td align="char" char="." rowspan="1" colspan="1">20</td>
                        <td align="center" rowspan="1" colspan="1">2.01 (1.28, 7.40)</td>
                        <td align="center" rowspan="1" colspan="1">2.97 (1.48, 5.23)</td>
                        <td align="char" char="." rowspan="1" colspan="1">10</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.55</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> LDL apoB-100</td>
                        <td align="center" rowspan="1" colspan="1">9.45 (7.97, 14.3)</td>
                        <td align="center" rowspan="1" colspan="1">14.3 (11.2, 17.5)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="char" char="." rowspan="1" colspan="1">32</td>
                        <td align="center" rowspan="1" colspan="1">12.9 (10.9, 17.4)</td>
                        <td align="center" rowspan="1" colspan="1">14.7 (12.0, 20.0)</td>
                        <td align="char" char="." rowspan="1" colspan="1">7</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.29</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> TRL apoB-48</td>
                        <td align="center" rowspan="1" colspan="1">1.02 (0.68, 1.71)</td>
                        <td align="center" rowspan="1" colspan="1">0.57 (0.23, 0.94)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−50</td>
                        <td align="center" rowspan="1" colspan="1">0.74 (0.60, 0.96)</td>
                        <td align="center" rowspan="1" colspan="1">0.80 (0.48, 1.13)</td>
                        <td align="center" rowspan="1" colspan="1">−9</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.04</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> HDL apoA-I</td>
                        <td align="center" rowspan="1" colspan="1">12.2 (10.9, 13.5)</td>
                        <td align="center" rowspan="1" colspan="1">10.7 (7.71, 13.7)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−11</td>
                        <td align="center" rowspan="1" colspan="1">12.0 (10.2, 15.6)</td>
                        <td align="center" rowspan="1" colspan="1">9.47 (8.71, 14.2)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−12</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.53</td>
                      </tr>
                      <tr>
                        <td colspan="8" rowspan="1">Percent conversion (%)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> TRL to IDL apoB-100</td>
                        <td align="center" rowspan="1" colspan="1">10.6 (7.92, 13.3)</td>
                        <td align="center" rowspan="1" colspan="1">12.1 (9.32, 23.5)</td>
                        <td align="char" char="." rowspan="1" colspan="1">27</td>
                        <td align="center" rowspan="1" colspan="1">10.5 (6.65, 34.4)</td>
                        <td align="center" rowspan="1" colspan="1">11.61 (6.13, 28.8)</td>
                        <td align="center" rowspan="1" colspan="1">−9</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.33</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> IDL to LDL apoB-100</td>
                        <td align="center" rowspan="1" colspan="1">100 (100, 100)</td>
                        <td align="center" rowspan="1" colspan="1">100 (100, 100)</td>
                        <td align="center" rowspan="1" colspan="1">…</td>
                        <td align="center" rowspan="1" colspan="1">100 (100, 100)</td>
                        <td align="center" rowspan="1" colspan="1">100 (100, 100)</td>
                        <td align="center" rowspan="1" colspan="1">…</td>
                        <td align="center" rowspan="1" colspan="1">…</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> TRL to LDL apoB-100</td>
                        <td align="center" rowspan="1" colspan="1">48.5 (26.6, 65.5)</td>
                        <td align="center" rowspan="1" colspan="1">79.6 (45.8, 92.3)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="char" char="." rowspan="1" colspan="1">39</td>
                        <td align="center" rowspan="1" colspan="1">70.1 (58.9, 83.8)</td>
                        <td align="center" rowspan="1" colspan="1">75.63 (67.7, 88.3)</td>
                        <td align="char" char="." rowspan="1" colspan="1">7</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.08</td>
                      </tr>
                      <tr>
                        <td colspan="2" rowspan="1">Absolute conversion rates (mg/kg/day)</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> TRL to IDL apoB-100</td>
                        <td align="center" rowspan="1" colspan="1">3.4 (1.1, 3.6)</td>
                        <td align="center" rowspan="1" colspan="1">2.7 (2.0, 4.0)</td>
                        <td align="char" char="." rowspan="1" colspan="1">20</td>
                        <td align="center" rowspan="1" colspan="1">2.0 (1.3, 7.4)</td>
                        <td align="center" rowspan="1" colspan="1">3.0 (1.5, 5.2)</td>
                        <td align="char" char="." rowspan="1" colspan="1">10</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.55</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> IDL to LDL apoB-100</td>
                        <td align="center" rowspan="1" colspan="1">3.4 (1.1, 3.6)</td>
                        <td align="center" rowspan="1" colspan="1">2.7 (2.0, 4.0)</td>
                        <td align="char" char="." rowspan="1" colspan="1">20</td>
                        <td align="center" rowspan="1" colspan="1">2.0 (1.3, 7.4)</td>
                        <td align="center" rowspan="1" colspan="1">3.0 (1.5, 5.2)</td>
                        <td align="char" char="." rowspan="1" colspan="1">10</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.55</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> TRL to LDL apoB-100</td>
                        <td align="center" rowspan="1" colspan="1">9.4 (8.0, 14.3)</td>
                        <td align="center" rowspan="1" colspan="1">14.3 (11.2, 17.5)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="char" char="." rowspan="1" colspan="1">32</td>
                        <td align="center" rowspan="1" colspan="1">12.9 (10.9, 17.4)</td>
                        <td align="center" rowspan="1" colspan="1">14.7 (12.0, 20.0)</td>
                        <td align="char" char="." rowspan="1" colspan="1">6</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.29</td>
                      </tr>
                      <tr>
                        <td colspan="8" rowspan="1">TRL apoB-100 direct catabolism</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">(mg/kg/day)</td>
                        <td align="center" rowspan="1" colspan="1">17 (7.20, 23.2)</td>
                        <td align="center" rowspan="1" colspan="1">4.4 (1.10, 15.9)<xref ref-type="table-fn" rid="tblfn8"><italic><sup>b</sup></italic></xref></td>
                        <td align="center" rowspan="1" colspan="1">−53</td>
                        <td align="center" rowspan="1" colspan="1">5.2 (1.90, 7.10)</td>
                        <td align="center" rowspan="1" colspan="1">5.4 (3.20, 7.50)</td>
                        <td align="char" char="." rowspan="1" colspan="1">3</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.01</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn>
                      <p>Data are presented as median (IQR).</p>
                    </fn>
                    <fn id="tblfn7">
                      <label>a</label>
                      <p>Comparison between change from baseline of high-fish vs. low-fish diet, n
= 10.</p>
                    </fn>
                    <fn id="tblfn8">
                      <label>b</label>
                      <p><italic>P</italic> &lt; 0.05 compared with corresponding baseline diet.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec>
                <title>Effects on TRL apoB-48 metabolism</title>
                <p>The effects of the TLC diets on TRL apoB-48 concentration and kinetics are shown in
<xref ref-type="table" rid="tbl4">Table 4</xref>. There were 27%, 32%, and 51%
decreases in TRL apoB-48 concentration, FCR, and PR, respectively, with the TLC
high-fish diet as compared with 6% and 8% increases in TRL apoB-48 concentration and
FCR, and an 11% decrease in PR with the TLC low-fish diet (<italic>P</italic>
= 0.04 for all).</p>
              </sec>
              <sec>
                <title>Effects on HDL apoA-I metabolism</title>
                <p>The TLC diets decreased HDL apoA-I concentration and PR by a comparable magnitude,
and neither diet altered HDL apoA-I FCR significantly (<xref ref-type="table" rid="tbl4">Table 4</xref>).</p>
              </sec>
              <sec>
                <title>Associations between absolute changes in TRL apoB-100 concentrations and kinetics
with fasting plasma FA concentrations</title>
                <p>The associations between the changes in TRL apoB-100 concentration and kinetics with
the changes in fasting plasma FA concentrations were explored (<xref ref-type="fig" rid="fig2"><bold>Fig. 2</bold></xref>). With the TLC high-fish diet, the changes
in TRL apoB-100 concentration were significantly correlated with the changes in
plasma oleic acid (<xref ref-type="fig" rid="fig2">Fig. 2A</xref>). The changes in
TRL apoB-100 PR were significantly correlated with the changes in plasma oleic acid
(<xref ref-type="fig" rid="fig2">Fig. 2B</xref>), EPA (<xref ref-type="fig" rid="fig2">Fig. 2C</xref>), and DHA (<xref ref-type="fig" rid="fig2">Fig.
2D</xref>). The changes in TRL-to-LDL apoB-100 conversion were significantly
correlated with the changes in plasma EPA (<xref ref-type="fig" rid="fig2">Fig.
2E</xref>). The changes in TRL apoB-100 FCR and TRL-toLDL apoB-100 conversion rate
were correlated with the changes in plasma DHA, but these failed to reach statistical
significance (<italic>r</italic> = 0.617, <italic>P</italic> = 0.07 and
<italic>r</italic> = 0.57, <italic>P</italic> = 0.11, respectively).
All of these associations were also observed with the TLC low-fish diet but were not
statistically significant.</p>
                <fig id="fig2" position="float">
                  <label>Fig. 2.</label>
                  <caption>
                    <p>Correlations between the changes in TRL apoB-100 concentration with changes in
plasma oleic acid (A), the changes in TRL apoB-100 production rate with changes
in plasma oleic acid (B), EPA (C), and DHA (D), and the changes in TRL-to-LDL
apoB-100 conversion rate with changes in plasma EPA (E) in the NCEP high-fish
diet group (n = 9; the plasma FA profile of one subject was not measured
during the study). Spearman correlation analyses were performed to examine the
statistical associations between changes from baseline in variables.</p>
                  </caption>
                  <graphic xlink:href="1958fig2"/>
                </fig>
              </sec>
            </sec>
            <sec sec-type="discussion">
              <title>DISCUSSION</title>
              <p>We provide new information on the effects of two diets adhering to the TLC diet
criteria, one high and the other low in dietary fish-derived n-3 FAs, on lipoprotein
metabolism in middle-aged and elderly men and women. The TLC high-fish diet decreased
postprandial plasma triglyceride concentration, with concomitant reductions in TRL
apoB-100 concentration, PR, and direct catabolism, and TRL apoB-48 concentration, FCR,
and PR. Both TLC diets had comparable effects on LDL apoB-100 and HDL apoA-I metabolism.
These effects were achieved with no significant change in body weight.</p>
              <sec>
                <title>Previous kinetics studies</title>
                <p>To date, only three studies have examined the effects of decreasing dietary saturated
fat together with increasing n-6 FAs on apoB-100 metabolism (<xref rid="bib37" ref-type="bibr">37</xref>–<xref rid="bib39" ref-type="bibr">39</xref>). These
studies have yielded inconsistent results due, in part, to different study
populations and/or the degree of saturated fat replacement with n-6 FAs (please see
supplementary data). No studies have examined the effects of these dietary changes on
TRL apoB-48 metabolism in humans. Furthermore, no studies have examined the effects
of dietary fish-derived n-3 FAs as part of a therapeutic low total and saturated fat,
and cholesterol diet on lipoprotein metabolism. Our study extends previous reports by
examining the effects of two TLC diets, in which total fat, saturated fat, and
cholesterol content were lowered, with one low and the other high in dietary
fish-derived FAs, on TRL, IDL, and LDL apoB-100, TRL apoB-48, and HDL apoA-I using
stable isotope methods.</p>
              </sec>
              <sec>
                <title>Effects of TLC diets on apoB-100 metabolism</title>
                <p>Studies in animals and humans have shown that the hypotriglyceridemic effect of n-3
FAs chiefly involves the suppression of TRL apoB-100 synthesis (<xref rid="bib22" ref-type="bibr">22</xref>–<xref rid="bib26" ref-type="bibr">26</xref>, <xref rid="bib40" ref-type="bibr">40</xref>, <xref rid="bib41" ref-type="bibr">41</xref>). This suppression is due to reduced triglyceride synthesis via inhibition
of diacylglycerol acyltransferase, FA synthase, and acetyl CoA carboxylase enzyme
activities (<xref rid="bib14" ref-type="bibr">14</xref>). N-3 FAs also enhance FA
β oxidation via a peroxisome proliferator-activated receptor-α-mediated
pathway resulting in decreased substrate availability for triglyceride formation
(<xref rid="bib14" ref-type="bibr">14</xref>). In addition, n-3 FAs suppress
transcription of the sterol regulatory element binding protein (SREBP)-1c gene and
hence, inhibit de novo lipogenesis (<xref rid="bib14" ref-type="bibr">14</xref>).
Furthermore, n-3 FAs may stimulate the post-endoplasmic reticulum (ER) presecretory
proteolysis pathway, thereby increasing the degradation of newly synthesized apoB
(<xref rid="bib42" ref-type="bibr">42</xref>). Our study concurred with earlier
human studies that n-3 FAs decrease TRL apoB-100 hepatic secretion and
concentration.</p>
                <p>Of interest, the associations between changes in TRL apoB-100 concentrations and PRs,
with fasting plasma FAs, particularly oleic acid, EPA, and DHA, are consistent with
prior in vitro studies. These studies, utilizing either HepG2 cells and/or perfused
rat liver, suggest that oleic acid stimulates apoB-100 secretion, without altering
apoB-100 mRNA levels, whereas EPA and DHA have the opposite effects (<xref rid="bib43" ref-type="bibr">43</xref>–<xref rid="bib45" ref-type="bibr">45</xref>). These observations, together with our findings, support the concept
of differential modes of action of individual FAs in regulating TRL apoB-100
secretion (<xref rid="bib43" ref-type="bibr">43</xref>).</p>
                <p>We observed that dietary fish-derived n-3 FAs decreased TRL apoB-100 direct
catabolism, and, by implication, conversion of TRL to LDL was increased. Consistent
with this observation, others (<xref rid="bib46" ref-type="bibr">46</xref>) have
shown that enrichment of n-3 FAs in TRL preferentially converts TRL to LDL.
Furthermore, a positive association between changes in TRL-to-LDL conversion with
changes in EPA, and a concomitant increase in LDL apoB-100 PR were observed. The
mechanism for the accelerated conversion of TRL to LDL, however, is unknown. TRL
particles enriched with n-3 FAs may be better substrates for lipolysis. Animal
studies suggest that fish oil increased margination of TRL (binding to LPL at the
endothelium) (<xref rid="bib47" ref-type="bibr">47</xref>). If TRL binds more tightly
to LPL, the period of interaction may be longer, resulting in the formation of
smaller remnants. This hypothesis is supported by experimental data indicating that
heparin injection in primates, which stimulates release of LPL from heparin sulfate
proteoglycans, transiently increased LDL concentrations (<xref rid="bib48" ref-type="bibr">48</xref>) and that fish oil supplementation in humans increased LPL
activity (<xref rid="bib46" ref-type="bibr">46</xref>). In addition, we cannot rule
out the possibility that higher n-3 FA intake results in the secretion of smaller and
less apoE-enriched TRL particles. Yamada et al. previously reported that apoE-poor
TRL particles are preferentially converted to LDL (<xref rid="bib49" ref-type="bibr">49</xref>). Of note, no change in TRL apoB-100 metabolism was observed with the
TLC low-fish diet. This supports the notion that the reductions in TRL apoB-100
secretion and altered TRL apoB-100 catabolism were chiefly an effect of dietary
fish-derived n-3 FAs.</p>
                <p>Moderate fat and low cholesterol diets are recommended nutritional modifications to
reduce CHD risk due, in part, to their hypocholesterolemic effects (<xref rid="bib4" ref-type="bibr">4</xref>–<xref rid="bib8" ref-type="bibr">8</xref>). In the present study, both TLC diets significantly reduced total, LDL
cholesterol, and LDL apoB-100 concentrations. This was chiefly due to increased LDL
apoB-100 FCR. Animal studies have reported increases in LDL apoB-100 FCR with reduced
dietary saturated fat and cholesterol intake (<xref rid="bib50" ref-type="bibr">50</xref>–<xref rid="bib53" ref-type="bibr">53</xref>). In addition, fat
and cholesterol feeding have been associated with a reduction in SREBP-2 and LDL
receptor mRNA expression (<xref rid="bib51" ref-type="bibr">51</xref>, <xref rid="bib52" ref-type="bibr">52</xref>, <xref rid="bib54" ref-type="bibr">54</xref>). Furthermore, postprandial enrichment of TRL particles with apoE after
fat ingestion was recently shown to inhibit LDL binding and uptake by the LDL
receptor in HepG2 cells (<xref rid="bib55" ref-type="bibr">55</xref>). Collectively,
these observations imply that reductions in dietary saturated fat and cholesterol,
may upregulate hepatic expression of LDL receptors and hence, binding and clearance
of LDL particles in vivo. Of note, the incorporation of dietary fish-derived n-3 FAs
did not confer additional effect on LDL apoB-100 FCR. The decrease in LDL apoB-100
concentration, however, was of a smaller magnitude relative to the TLC low-fish diet,
in spite of comparable increases in LDL apoB-100 FCR. This is probably due to the
enhanced TRL-to-LDL apoB-100 conversion with the high-fish diet. Nonetheless, the
decrease in total plasma apoB-100 concentration was similar with both TLC diets.</p>
              </sec>
              <sec>
                <title>Effects of TLC diets on TRL apoB-48 metabolism</title>
                <p>The assembly and secretion of chylomicrons by the small intestines in humans is a
complex process that brings together the very large and highly amphipathic apoB
polypeptide and four different classes of lipids in a fixed sequence. Microsomal
transfer protein (MTP) plays a key role in the assembly and secretion of these
particles by transferring lipids from the ER membrane to the lipid binding domains of
nascent apoB-48, resulting in small, dense particles that are triglyceride poor
(<xref rid="bib56" ref-type="bibr">56</xref>, <xref rid="bib57" ref-type="bibr">57</xref>). In addition, MTP facilitates the production of small triglyceride
droplets in the smooth ER. It is hypothesized that these droplets and small, dense
apoB-48 fuse to form mature chylomicron particles (<xref rid="bib58" ref-type="bibr">58</xref>).</p>
                <p>We showed, for the first time, that dietary fish-derived n-3 FAs decreased TRL
apoB-48 concentration by decreasing TRL apoB-48 PR in humans. Our finding is
consistent with observations from in vitro and animal studies that showed that n-3
FAs suppressed TRL apoB-48 synthesis (<xref rid="bib59" ref-type="bibr">59</xref>–<xref rid="bib62" ref-type="bibr">62</xref>) either by decreasing
apoB-48 mRNA expression (<xref rid="bib60" ref-type="bibr">60</xref>) and/or
increasing posttranslational degradation of newly synthesized apoB-48 (<xref rid="bib59" ref-type="bibr">59</xref>, <xref rid="bib61" ref-type="bibr">61</xref>). It is also plausible that additional pathways, including altered MTP
mRNA expression and activity, may explain changes in apoB-48 PR, although future
studies are required. Of note, TRL apoB-48 FCR was significantly decreased with the
TLC high-fish diet. The exact mechanism for the reduction in TRL apoB-48 FCR is,
however, unclear. It is possible that these particles were less triglyceride-enriched
and were, therefore, poorer substrates for lipoprotein lipase.</p>
              </sec>
              <sec>
                <title>Effects of TLC diets on HDL apoA-I metabolism</title>
                <p>We showed that both TLC diets reduced HDL cholesterol and apoA-I concentrations by
decreasing HDL apoA-I production to a similar extent. From these data, it can be
inferred that these changes reflect the reductions in dietary saturated fat and
cholesterol rather than fish intake per se. Animal studies have shown that dietary
saturated fat and cholesterol increased HDL cholesterol and apoA-I concentrations
between 36% and 67% (<xref rid="bib52" ref-type="bibr">52</xref>, <xref rid="bib63" ref-type="bibr">63</xref>–<xref rid="bib65" ref-type="bibr">65</xref>), comparable to what we observed in our studies in humans. Similarly,
Vessby et al. reported reductions in HDL cholesterol (−15%) and apoA-I
(−9%) concentrations with a diet low in total fat (35% energy from fat) in nine
hypercholesterolemic subjects (<xref rid="bib66" ref-type="bibr">66</xref>).</p>
                <p>The decrease in HDL apoA-I PR may be due to downregulation of apoA-I mRNA expression
with dietary fat and cholesterol reduction (<xref rid="bib64" ref-type="bibr">64</xref>, <xref rid="bib67" ref-type="bibr">67</xref>). Studies have shown that
dietary saturated fat and cholesterol intake upregulates posttranslational apoA-I
expression, involving either increased translation of the apoA-I mRNA or less
intracellular apoA-I degradation (<xref rid="bib64" ref-type="bibr">64</xref>).
Dietary fat has also been shown to increase the fraction of apoA-I mRNA in the
translating pool (<xref rid="bib67" ref-type="bibr">67</xref>). Hence, reductions in
dietary fat and cholesterol may have decreased HDL apoA-I production. Whether the
lower dietary fat and cholesterol translates to a need for less HDL-mediated
cholesterol removal and hence, lower HDL apoA-I PR, needs further exploration (<xref rid="bib64" ref-type="bibr">64</xref>, <xref rid="bib68" ref-type="bibr">68</xref>). Of note, the total cholesterol:HDL cholesterol ratio, a powerful
predictor of CHD risk, was significantly decreased in a pooled analysis of both diets
(−6.2%, <italic>P</italic> &lt; 0.01). Hence, we propose that the reduction in
HDL cholesterol with the TLC diets should not be viewed as a negative outcome with
regard to CHD risk.</p>
              </sec>
              <sec>
                <title>Limitations</title>
                <p>Several limitations are noteworthy. We studied middle-aged and elderly subjects with
mild-to-moderate hypercholesterolemia. Studies in hypertriglyceridemic and type 2
diabetic subjects are warranted. Our study examined the combined effects of
decreasing dietary total fat, saturated fat, and cholesterol content. Future studies
to distinguish the independent effects of these dietary macronutrients, as well as
the impact of specific carbohydrate (<xref rid="bib69" ref-type="bibr">69</xref>),
are required. TRL subspecies and TRL triglycerides kinetics were not examined, but we
anticipate that their production will also be reduced with n-3 FA consumption.
ApoB-containing particles are subject to modifications by hepatic lipases and may
exhibit kinetic and structural heterogeneity based on the content of regulatory
apolipoproteins, including apoC-III and apoE (<xref rid="bib70" ref-type="bibr">70</xref>). Measurements of lipase masses and activities, as well as the
concentrations and kinetics of key regulatory apolipoproteins, may further elucidate
our findings.</p>
              </sec>
              <sec>
                <title>Implications and conclusions</title>
                <p>Our study showed that the consumption of dietary fish-derived n-3 FAs against the
background of the TLC therapeutic diet decreased plasma triglyceride and TRL
concentrations. This is particularly relevant in light of recent evidence that
nonfasting plasma triglycerides are risk factors for CHD (<xref rid="bib71" ref-type="bibr">71</xref>–<xref rid="bib73" ref-type="bibr">73</xref>). The
reduction in TRL concentration with n-3 FA intake was, chiefly, a function of
decreased hepatic and intestinal TRL particle production. Consumption of various TLC
diets, low in fat, saturated fat, and cholesterol content, was associated with
significant reductions in LDL cholesterol and LDL apoB-100 due to increased
catabolism of LDL particles. These diets were also associated with decreases in HDL
cholesterol, a function of decreased HDL apoA-I production. The changes in
lipoprotein metabolism with the TLC diets may provide a mechanistic explanation for
the CHD benefits reported in intervention studies (<xref rid="bib6" ref-type="bibr">6</xref>, <xref rid="bib11" ref-type="bibr">11</xref>–<xref rid="bib13" ref-type="bibr">13</xref>, <xref rid="bib74" ref-type="bibr">74</xref>). Our study
supports the nutritional and lifestyle recommendations of the NCEP and AHA for the
prevention of CHD to lower saturated fat and cholesterol to that of the TLC diet and
increase the consumption of fish-derived FAs.</p>
              </sec>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <supplementary-material id="PMC_1" content-type="local-data">
                <caption>
                  <title>Supplemental Table 1</title>
                </caption>
                <media mimetype="text" mime-subtype="html" xlink:href="supp_53_9_1958__index.html"/>
                <media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="supp_P024315_jlr.P024315-1.pdf"/>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn fn-type="abbr" id="gloss1">
                <p>
                  <def-list>
                    <title>Abbreviations:</title>
                    <def-item>
                      <term>AHA</term>
                      <def>
                        <p>American Heart Association</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>CHD</term>
                      <def>
                        <p>coronary heart disease</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>CVD</term>
                      <def>
                        <p>cardiovascular disease</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>DHA</term>
                      <def>
                        <p>docosahexaenoic acid</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>EPA</term>
                      <def>
                        <p>eicosapentaenoic acid</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>ER</term>
                      <def>
                        <p>endoplasmic reticulum</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>FCR</term>
                      <def>
                        <p>fractional catabolic rate</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>MTP</term>
                      <def>
                        <p>microsomal transfer protein</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>NCEP</term>
                      <def>
                        <p>National Cholesterol Education Program</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>PR</term>
                      <def>
                        <p>production rate</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>SREBP</term>
                      <def>
                        <p>sterol regulatory element binding protein</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>TLC</term>
                      <def>
                        <p>Therapeutic Lifestyle Change</p>
                      </def>
                    </def-item>
                    <def-item>
                      <term>TRL</term>
                      <def>
                        <p>triglyceride-rich lipoprotein</p>
                      </def>
                    </def-item>
                  </def-list>
                </p>
              </fn>
              <fn fn-type="financial-disclosure">
                <p>The study was supported by Grants HL-39326 and HL-56895 from the National Institute
of Health and contract 1950-51000-072-02S from the U.S. Department of Agriculture
Research Services. E.M.M.O. is supported by a National Health and Medical Research
Council (NHMRC) of Australia Postdoctoral Research Fellowship. P.H.R.B. is an NHMRC
Senior Research Fellow. All authors declare that there are no potential sources of
conflict of interest.</p>
              </fn>
            </fn-group>
            <ref-list>
              <title>REFERENCES</title>
              <ref id="bib1">
                <label>1.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grundy</surname><given-names>S. M.</given-names></name><name><surname>Cleeman</surname><given-names>J. I.</given-names></name><name><surname>Merz</surname><given-names>C. N.</given-names></name><name><surname>Brewer</surname><given-names>H. B.</given-names><suffix>Jr</suffix></name><name><surname>Clark</surname><given-names>L. T.</given-names></name><name><surname>Hunninghake</surname><given-names>D. B.</given-names></name><name><surname>Pasternak</surname><given-names>R. C.</given-names></name><name><surname>Smith</surname><given-names>S. C.</given-names><suffix>Jr</suffix></name><name><surname>Stone</surname><given-names>N. J.</given-names></name></person-group><year>2004</year><article-title>Implications of recent clinical
trials for the National Cholesterol Education Program Adult Treatment Panel III
guidelines</article-title>. <source>Circulation.</source><volume>110</volume>: <fpage>227</fpage>–<lpage>239</lpage>.<pub-id pub-id-type="pmid">15249516</pub-id></mixed-citation>
              </ref>
              <ref id="bib2">
                <label>2.</label>
                <mixed-citation publication-type="journal"><collab>Adult Treatment Panel III</collab>.
<year>2001</year><article-title>Executive Summary of the Third Report of the
National Cholesterol Education Program (NCEP) Expert Panel on Detection,
Evaluation, and Treatment of High Blood Cholesterol in Adults</article-title>.
<source>J. Am. Med. Assoc.</source><volume>285</volume>: <fpage>2486</fpage>–<lpage>2497</lpage>.</mixed-citation>
              </ref>
              <ref id="bib3">
                <label>3.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krauss</surname><given-names>R. M.</given-names></name><name><surname>Eckel</surname><given-names>R. H.</given-names></name><name><surname>Howard</surname><given-names>B.</given-names></name><name><surname>Appel</surname><given-names>L. J.</given-names></name><name><surname>Daniels</surname><given-names>S. R.</given-names></name><name><surname>Deckelbaum</surname><given-names>R. J.</given-names></name><name><surname>Erdman</surname><given-names>J. W.</given-names><suffix>Jr</suffix></name><name><surname>Kris-Etherton</surname><given-names>P.</given-names></name><name><surname>Goldberg</surname><given-names>I. J.</given-names></name><name><surname>Kotchen</surname><given-names>T. A.</given-names></name><etal/></person-group><year>2000</year><article-title>AHA Dietary Guidelines: revision
2000: A statement for healthcare professionals from the Nutrition Committee of the
American Heart Association</article-title>. <source>Circulation.</source><volume>102</volume>: <fpage>2284</fpage>–<lpage>2299</lpage>.<pub-id pub-id-type="pmid">11056107</pub-id></mixed-citation>
              </ref>
              <ref id="bib4">
                <label>4.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berglund</surname><given-names>L.</given-names></name><name><surname>Lefevre</surname><given-names>M.</given-names></name><name><surname>Ginsberg</surname><given-names>H. N.</given-names></name><name><surname>Kris-Etherton</surname><given-names>P. M.</given-names></name><name><surname>Elmer</surname><given-names>P. J.</given-names></name><name><surname>Stewart</surname><given-names>P. W.</given-names></name><name><surname>Ershow</surname><given-names>A.</given-names></name><name><surname>Pearson</surname><given-names>T. A.</given-names></name><name><surname>Dennis</surname><given-names>B. H.</given-names></name><name><surname>Roheim</surname><given-names>P. S.</given-names></name><etal/></person-group><year>2007</year><article-title>Comparison of monounsaturated fat
with carbohydrates as a replacement for saturated fat in subjects with a high
metabolic risk profile: studies in the fasting and postprandial
states</article-title>. <source>Am. J. Clin. Nutr.</source><volume>86</volume>: <fpage>1611</fpage>–<lpage>1620</lpage>.<pub-id pub-id-type="pmid">18065577</pub-id></mixed-citation>
              </ref>
              <ref id="bib5">
                <label>5.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent-Baudry</surname><given-names>S.</given-names></name><name><surname>Defoort</surname><given-names>C.</given-names></name><name><surname>Gerber</surname><given-names>M.</given-names></name><name><surname>Bernard</surname><given-names>M. C.</given-names></name><name><surname>Verger</surname><given-names>P.</given-names></name><name><surname>Helal</surname><given-names>O.</given-names></name><name><surname>Portugal</surname><given-names>H.</given-names></name><name><surname>Planells</surname><given-names>R.</given-names></name><name><surname>Grolier</surname><given-names>P.</given-names></name><name><surname>Amiot-Carlin</surname><given-names>M. J.</given-names></name><etal/></person-group><year>2005</year><article-title>The Medi-RIVAGE study: reduction
of cardiovascular disease risk factors after a 3-mo intervention with a
Mediterranean-type diet or a low-fat diet</article-title>. <source>Am. J. Clin.
Nutr.</source><volume>82</volume>: <fpage>964</fpage>–<lpage>971</lpage>.<pub-id pub-id-type="pmid">16280426</pub-id></mixed-citation>
              </ref>
              <ref id="bib6">
                <label>6.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obarzanek</surname><given-names>E.</given-names></name><name><surname>Sacks</surname><given-names>F. M.</given-names></name><name><surname>Vollmer</surname><given-names>W. M.</given-names></name><name><surname>Bray</surname><given-names>G. A.</given-names></name><name><surname>Miller</surname><given-names>E. R.</given-names><suffix>III</suffix></name><name><surname>Lin</surname><given-names>P. H.</given-names></name><name><surname>Karanja</surname><given-names>N. M.</given-names></name><name><surname>Most-Windhauser</surname><given-names>M. M.</given-names></name><name><surname>Moore</surname><given-names>T. J.</given-names></name><name><surname>Swain</surname><given-names>J. F.</given-names></name><etal/></person-group><year>2001</year><article-title>Effects on blood lipids of a blood
pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH)
Trial</article-title>. <source>Am. J. Clin. Nutr.</source><volume>74</volume>: <fpage>80</fpage>–<lpage>89</lpage>.<pub-id pub-id-type="pmid">11451721</pub-id></mixed-citation>
              </ref>
              <ref id="bib7">
                <label>7.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R. B.</given-names></name><name><surname>Dubnov</surname><given-names>G.</given-names></name><name><surname>Niaz</surname><given-names>M. A.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Rastogi</surname><given-names>S. S.</given-names></name><name><surname>Manor</surname><given-names>O.</given-names></name><name><surname>Pella</surname><given-names>D.</given-names></name><name><surname>Berry</surname><given-names>E. M.</given-names></name></person-group><year>2002</year><article-title>Effect of an Indo-Mediterranean
diet on progression of coronary artery disease in high risk patients
(Indo-Mediterranean Diet Heart Study): a randomised single-blind
trial</article-title>. <source>Lancet.</source><volume>360</volume>: <fpage>1455</fpage>–<lpage>1461</lpage>.<pub-id pub-id-type="pmid">12433513</pub-id></mixed-citation>
              </ref>
              <ref id="bib8">
                <label>8.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knopp</surname><given-names>R. H.</given-names></name><name><surname>Retzlaff</surname><given-names>B.</given-names></name><name><surname>Walden</surname><given-names>C.</given-names></name><name><surname>Fish</surname><given-names>B.</given-names></name><name><surname>Buck</surname><given-names>B.</given-names></name><name><surname>McCann</surname><given-names>B.</given-names></name></person-group><year>2000</year><article-title>One-year effects of increasingly
fat-restricted, carbohydrate-enriched diets on lipoprotein levels in free-living
subjects</article-title>. <source>Proc. Soc. Exp. Biol. Med.</source><volume>225</volume>: <fpage>191</fpage>–<lpage>199</lpage>.<pub-id pub-id-type="pmid">11082213</pub-id></mixed-citation>
              </ref>
              <ref id="bib9">
                <label>9.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Z.</given-names></name><name><surname>Welty</surname><given-names>F. K.</given-names></name><name><surname>Dolnikowski</surname><given-names>G. G.</given-names></name><name><surname>Lichtenstein</surname><given-names>A. H.</given-names></name><name><surname>Schaefer</surname><given-names>E. J.</given-names></name></person-group><year>2001</year><article-title>Effects of a National Cholesterol
Education Program Step II Diet on apolipoprotein A-IV metabolism within
triacylglycerol-rich lipoproteins and plasma</article-title>. <source>Am. J. Clin.
Nutr.</source><volume>74</volume>: <fpage>308</fpage>–<lpage>314</lpage>.<pub-id pub-id-type="pmid">11522553</pub-id></mixed-citation>
              </ref>
              <ref id="bib10">
                <label>10.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaefer</surname><given-names>E. J.</given-names></name><name><surname>Lamon-Fava</surname><given-names>S.</given-names></name><name><surname>Ausman</surname><given-names>L. M.</given-names></name><name><surname>Ordovas</surname><given-names>J. M.</given-names></name><name><surname>Clevidence</surname><given-names>B. A.</given-names></name><name><surname>Judd</surname><given-names>J. T.</given-names></name><name><surname>Goldin</surname><given-names>B. R.</given-names></name><name><surname>Woods</surname><given-names>M.</given-names></name><name><surname>Gorbach</surname><given-names>S.</given-names></name><name><surname>Lichtenstein</surname><given-names>A. H.</given-names></name></person-group><year>1997</year><article-title>Individual variability in
lipoprotein cholesterol response to National Cholesterol Education Program Step 2
diets</article-title>. <source>Am. J. Clin. Nutr.</source><volume>65</volume>: <fpage>823</fpage>–<lpage>830</lpage>.<pub-id pub-id-type="pmid">9062535</pub-id></mixed-citation>
              </ref>
              <ref id="bib11">
                <label>11.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaefer</surname><given-names>E. J.</given-names></name><name><surname>Lichtenstein</surname><given-names>A. H.</given-names></name><name><surname>Lamon-Fava</surname><given-names>S.</given-names></name><name><surname>Contois</surname><given-names>J. H.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Goldin</surname><given-names>B. R.</given-names></name><name><surname>Rasmussen</surname><given-names>H.</given-names></name><name><surname>McNamara</surname><given-names>J. R.</given-names></name><name><surname>Ordovas</surname><given-names>J. M.</given-names></name></person-group><year>1996</year><article-title>Effects of National Cholesterol
Education Program Step 2 diets relatively high or relatively low in fish-derived
fatty acids on plasma lipoproteins in middle-aged and elderly
subjects</article-title>. <source>Am. J. Clin. Nutr.</source><volume>63</volume>: <fpage>234</fpage>–<lpage>241</lpage>.<pub-id pub-id-type="pmid">8561065</pub-id></mixed-citation>
              </ref>
              <ref id="bib12">
                <label>12.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saravanan</surname><given-names>P.</given-names></name><name><surname>Davidson</surname><given-names>N. C.</given-names></name><name><surname>Schmidt</surname><given-names>E. B.</given-names></name><name><surname>Calder</surname><given-names>P. C.</given-names></name></person-group><year>2010</year><article-title>Cardiovascular effects of marine
omega-3 fatty acids</article-title>. <source>Lancet.</source><volume>376</volume>: <fpage>540</fpage>–<lpage>550</lpage>.<pub-id pub-id-type="pmid">20638121</pub-id></mixed-citation>
              </ref>
              <ref id="bib13">
                <label>13.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavie</surname><given-names>C. J.</given-names></name><name><surname>Milani</surname><given-names>R. V.</given-names></name><name><surname>Mehra</surname><given-names>M. R.</given-names></name><name><surname>Ventura</surname><given-names>H. O.</given-names></name></person-group><year>2009</year><article-title>Omega-3 polyunsaturated fatty
acids and cardiovascular diseases</article-title>. <source>J. Am. Coll.
Cardiol.</source><volume>54</volume>: <fpage>585</fpage>–<lpage>594</lpage>.<pub-id pub-id-type="pmid">19660687</pub-id></mixed-citation>
              </ref>
              <ref id="bib14">
                <label>14.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bays</surname><given-names>H. E.</given-names></name><name><surname>Tighe</surname><given-names>A. P.</given-names></name><name><surname>Sadovsky</surname><given-names>R.</given-names></name><name><surname>Davidson</surname><given-names>M. H.</given-names></name></person-group><year>2008</year><article-title>Prescription omega-3 fatty acids
and their lipid effects: physiologic mechanisms of action and clinical
implications</article-title>. <source>Expert Rev. Cardiovasc. Ther.</source><volume>6</volume>: <fpage>391</fpage>–<lpage>409</lpage>.<pub-id pub-id-type="pmid">18327998</pub-id></mixed-citation>
              </ref>
              <ref id="bib15">
                <label>15.</label>
                <mixed-citation publication-type="journal"><article-title>Gruppo Italiano per lo Studio della
Sopravvivenza nell'Infarto miocardico</article-title>. <year>1999</year><article-title>Dietary supplementation with n-3 polyunsaturated fatty acids and
vitamin E after myocardial infarction: results of the GISSI-Prevenzione
trial</article-title>. <source>Lancet.</source><volume>354</volume>: <fpage>447</fpage>–<lpage>455</lpage>.</mixed-citation>
              </ref>
              <ref id="bib16">
                <label>16.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kromhout</surname><given-names>D.</given-names></name><name><surname>Giltay</surname><given-names>E. J.</given-names></name><name><surname>Geleijnse</surname><given-names>J. M.</given-names></name></person-group><year>2010</year><article-title>N-3 fatty acids and cardiovascular
events after myocardial infarction</article-title>. <source>N. Engl. J.
Med.</source><volume>363</volume>: <fpage>2015</fpage>–<lpage>2026</lpage>.<pub-id pub-id-type="pmid">20929341</pub-id></mixed-citation>
              </ref>
              <ref id="bib17">
                <label>17.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burr</surname><given-names>M. L.</given-names></name><name><surname>Fehily</surname><given-names>A. M.</given-names></name><name><surname>Gilbert</surname><given-names>J. F.</given-names></name><name><surname>Rogers</surname><given-names>S.</given-names></name><name><surname>Holliday</surname><given-names>R. M.</given-names></name><name><surname>Sweetnam</surname><given-names>P. M.</given-names></name><name><surname>Elwood</surname><given-names>P. C.</given-names></name><name><surname>Deadman</surname><given-names>N. M.</given-names></name></person-group><year>1989</year><article-title>Effects of changes in fat, fish,
and fibre intakes on death and myocardial reinfarction: diet and reinfarction
trial (DART)</article-title>. <source>Lancet.</source><volume>2</volume>: <fpage>757</fpage>–<lpage>761</lpage>.<pub-id pub-id-type="pmid">2571009</pub-id></mixed-citation>
              </ref>
              <ref id="bib18">
                <label>18.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoyama</surname><given-names>M.</given-names></name><name><surname>Origasa</surname><given-names>H.</given-names></name><name><surname>Matsuzaki</surname><given-names>M.</given-names></name><name><surname>Matsuzawa</surname><given-names>Y.</given-names></name><name><surname>Saito</surname><given-names>Y.</given-names></name><name><surname>Ishikawa</surname><given-names>Y.</given-names></name><name><surname>Oikawa</surname><given-names>S.</given-names></name><name><surname>Sasaki</surname><given-names>J.</given-names></name><name><surname>Hishida</surname><given-names>H.</given-names></name><name><surname>Itakura</surname><given-names>H.</given-names></name><etal/></person-group><year>2007</year><article-title>Effects of eicosapentaenoic acid
on major coronary events in hypercholesterolaemic patients (JELIS): a randomised
open-label, blinded endpoint analysis</article-title>. <source>Lancet.</source><volume>369</volume>: <fpage>1090</fpage>–<lpage>1098</lpage>.<pub-id pub-id-type="pmid">17398308</pub-id></mixed-citation>
              </ref>
              <ref id="bib19">
                <label>19.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rauch</surname><given-names>B.</given-names></name><name><surname>Schiele</surname><given-names>R.</given-names></name><name><surname>Schneider</surname><given-names>S.</given-names></name><name><surname>Diller</surname><given-names>F.</given-names></name><name><surname>Victor</surname><given-names>N.</given-names></name><name><surname>Gohlke</surname><given-names>H.</given-names></name><name><surname>Gottwik</surname><given-names>M.</given-names></name><name><surname>Steinbeck</surname><given-names>G.</given-names></name><name><surname>Del Castillo</surname><given-names>U.</given-names></name><name><surname>Sack</surname><given-names>R.</given-names></name><etal/></person-group><year>2010</year><article-title>OMEGA, a randomized,
placebo-controlled trial to test the effect of highly purified omega-3 fatty acids
on top of modern guideline-adjusted therapy after myocardial
infarction</article-title>. <source>Circulation.</source><volume>122</volume>: <fpage>2152</fpage>–<lpage>2159</lpage>.<pub-id pub-id-type="pmid">21060071</pub-id></mixed-citation>
              </ref>
              <ref id="bib20">
                <label>20.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galan</surname><given-names>P.</given-names></name><name><surname>Kesse-Guyot</surname><given-names>E.</given-names></name><name><surname>Czernichow</surname><given-names>S.</given-names></name><name><surname>Briancon</surname><given-names>S.</given-names></name><name><surname>Blacher</surname><given-names>J.</given-names></name><name><surname>Hercberg</surname><given-names>S.</given-names></name></person-group><article-title>Effects of B vitamins and omega 3 fatty acids on
cardiovascular diseases: a randomised placebo controlled trial</article-title>.
<source>BMJ</source>. <comment>Epub ahead of print. November 9, 2010; doi:
10.1136/bmj.c6273.2010</comment>.</mixed-citation>
              </ref>
              <ref id="bib21">
                <label>21.</label>
                <mixed-citation publication-type="journal"><collab>The ORIGIN Trial Investigators</collab>.
<year>2012</year><comment>N-3 fatty acids and cardiovascular outcomes in
patients with dysglycemia. <italic>N. Engl. J. Med.</italic> Epub ahead of print,
June 11, 2012. doi: 10.1056/NEJMoa1203859</comment>.</mixed-citation>
              </ref>
              <ref id="bib22">
                <label>22.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nestel</surname><given-names>P. J.</given-names></name><name><surname>Connor</surname><given-names>W. E.</given-names></name><name><surname>Reardon</surname><given-names>M. F.</given-names></name><name><surname>Connor</surname><given-names>S.</given-names></name><name><surname>Wong</surname><given-names>S.</given-names></name><name><surname>Boston</surname><given-names>R.</given-names></name></person-group><year>1984</year><article-title>Suppression by diets rich in fish
oil of very low density lipoprotein production in man</article-title>. <source>J.
Clin. Invest.</source><volume>74</volume>: <fpage>82</fpage>–<lpage>89</lpage>.<pub-id pub-id-type="pmid">6736254</pub-id></mixed-citation>
              </ref>
              <ref id="bib23">
                <label>23.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bordin</surname><given-names>P.</given-names></name><name><surname>Bodamer</surname><given-names>O. A.</given-names></name><name><surname>Venkatesan</surname><given-names>S.</given-names></name><name><surname>Gray</surname><given-names>R. M.</given-names></name><name><surname>Bannister</surname><given-names>P. A.</given-names></name><name><surname>Halliday</surname><given-names>D.</given-names></name></person-group><year>1998</year><article-title>Effects of fish oil
supplementation on apolipoprotein B100 production and lipoprotein metabolism in
normolipidaemic males</article-title>. <source>Eur. J. Clin. Nutr.</source><volume>52</volume>: <fpage>104</fpage>–<lpage>109</lpage>.<pub-id pub-id-type="pmid">9505154</pub-id></mixed-citation>
              </ref>
              <ref id="bib24">
                <label>24.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huff</surname><given-names>M. W.</given-names></name><name><surname>Telford</surname><given-names>D. E.</given-names></name></person-group><year>1989</year><article-title>Dietary fish oil increases
conversion of very low density lipoprotein apoprotein B to low density
lipoprotein</article-title>. <source>Arteriosclerosis.</source><volume>9</volume>: <fpage>58</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="pmid">2912422</pub-id></mixed-citation>
              </ref>
              <ref id="bib25">
                <label>25.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>W. R.</given-names></name><name><surname>Zech</surname><given-names>L. A.</given-names></name><name><surname>Stacpoole</surname><given-names>P. W.</given-names></name></person-group><year>1998</year><article-title>Apolipoprotein B metabolism in
hypertriglyceridemic diabetic patients administered either a fish oil- or
vegetable oil-enriched diet</article-title>. <source>J. Lipid Res.</source><volume>39</volume>: <fpage>388</fpage>–<lpage>401</lpage>.<pub-id pub-id-type="pmid">9507999</pub-id></mixed-citation>
              </ref>
              <ref id="bib26">
                <label>26.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>D. C.</given-names></name><name><surname>Watts</surname><given-names>G. F.</given-names></name><name><surname>Mori</surname><given-names>T. A.</given-names></name><name><surname>Barrett</surname><given-names>P. H.</given-names></name><name><surname>Redgrave</surname><given-names>T. G.</given-names></name><name><surname>Beilin</surname><given-names>L. J.</given-names></name></person-group><year>2003</year><article-title>Randomized controlled trial of the
effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100
and chylomicron remnants in men with visceral obesity</article-title>. <source>Am.
J. Clin. Nutr.</source><volume>77</volume>: <fpage>300</fpage>–<lpage>307</lpage>.<pub-id pub-id-type="pmid">12540386</pub-id></mixed-citation>
              </ref>
              <ref id="bib27">
                <label>27.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohn</surname><given-names>J. S.</given-names></name><name><surname>Wagner</surname><given-names>D. A.</given-names></name><name><surname>Cohn</surname><given-names>S. D.</given-names></name><name><surname>Millar</surname><given-names>J. S.</given-names></name><name><surname>Schaefer</surname><given-names>E. J.</given-names></name></person-group><year>1990</year><article-title>Measurement of very low density
and low density lipoprotein apolipoprotein (Apo) B-100 and high density
lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect
of fasting and feeding</article-title>. <source>J. Clin. Invest.</source><volume>85</volume>: <fpage>804</fpage>–<lpage>811</lpage>.<pub-id pub-id-type="pmid">2107210</pub-id></mixed-citation>
              </ref>
              <ref id="bib28">
                <label>28.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welty</surname><given-names>F. K.</given-names></name><name><surname>Lichtenstein</surname><given-names>A. H.</given-names></name><name><surname>Barrett</surname><given-names>P. H.</given-names></name><name><surname>Dolnikowski</surname><given-names>G. G.</given-names></name><name><surname>Schaefer</surname><given-names>E. J.</given-names></name></person-group><year>1999</year><article-title>Human apolipoprotein (Apo) B-48
and ApoB-100 kinetics with stable isotopes</article-title>. <source>Arterioscler.
Thromb. Vasc. Biol.</source><volume>19</volume>: <fpage>2966</fpage>–<lpage>2974</lpage>.<pub-id pub-id-type="pmid">10591677</pub-id></mixed-citation>
              </ref>
              <ref id="bib29">
                <label>29.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthan</surname><given-names>N. R.</given-names></name><name><surname>Jalbert</surname><given-names>S. M.</given-names></name><name><surname>Barrett</surname><given-names>P. H.</given-names></name><name><surname>Dolnikowski</surname><given-names>G. G.</given-names></name><name><surname>Schaefer</surname><given-names>E. J.</given-names></name><name><surname>Lichtenstein</surname><given-names>A. H.</given-names></name></person-group><year>2008</year><article-title>Gender-specific differences in the
kinetics of nonfasting TRL, IDL, and LDL apolipoprotein B-100 in men and
premenopausal women</article-title>. <source>Arterioscler. Thromb. Vasc.
Biol.</source><volume>28</volume>: <fpage>1838</fpage>–<lpage>1843</lpage>.<pub-id pub-id-type="pmid">18658047</pub-id></mixed-citation>
              </ref>
              <ref id="bib30">
                <label>30.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welty</surname><given-names>F. K.</given-names></name><name><surname>Lichtenstein</surname><given-names>A. H.</given-names></name><name><surname>Barrett</surname><given-names>P. H.</given-names></name><name><surname>Dolnikowski</surname><given-names>G. G.</given-names></name><name><surname>Ordovas</surname><given-names>J. M.</given-names></name><name><surname>Schaefer</surname><given-names>E. J.</given-names></name></person-group><year>1997</year><article-title>Decreased production and increased
catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100
heterozygotes</article-title>. <source>Arterioscler. Thromb. Vasc. Biol.</source><volume>17</volume>: <fpage>881</fpage>–<lpage>888</lpage>.<pub-id pub-id-type="pmid">9157951</pub-id></mixed-citation>
              </ref>
              <ref id="bib31">
                <label>31.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ordovas</surname><given-names>J. M.</given-names></name><name><surname>Peterson</surname><given-names>J. P.</given-names></name><name><surname>Santaniello</surname><given-names>P.</given-names></name><name><surname>Cohn</surname><given-names>J. S.</given-names></name><name><surname>Wilson</surname><given-names>P. W.</given-names></name><name><surname>Schaefer</surname><given-names>E. J.</given-names></name></person-group><year>1987</year><article-title>Enzyme-linked immunosorbent assay
for human plasma apolipoprotein B</article-title>. <source>J. Lipid Res.</source><volume>28</volume>: <fpage>1216</fpage>–<lpage>1224</lpage>.<pub-id pub-id-type="pmid">3681146</pub-id></mixed-citation>
              </ref>
              <ref id="bib32">
                <label>32.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zilversmit</surname><given-names>D. B.</given-names></name><name><surname>Shea</surname><given-names>T. M.</given-names></name></person-group><year>1989</year><article-title>Quantitation of apoB-48 and
apoB-100 by gel scanning or radio-iodination</article-title>. <source>J. Lipid
Res.</source><volume>30</volume>: <fpage>1639</fpage>–<lpage>1646</lpage>.<pub-id pub-id-type="pmid">2614266</pub-id></mixed-citation>
              </ref>
              <ref id="bib33">
                <label>33.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lepage</surname><given-names>G.</given-names></name><name><surname>Roy</surname><given-names>C. C.</given-names></name></person-group><year>1986</year><article-title>Direct transesterification of all
classes of lipids in a one-step reaction</article-title>. <source>J. Lipid
Res.</source><volume>27</volume>: <fpage>114</fpage>–<lpage>120</lpage>.<pub-id pub-id-type="pmid">3958609</pub-id></mixed-citation>
              </ref>
              <ref id="bib34">
                <label>34.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichtenstein</surname><given-names>A. H.</given-names></name><name><surname>Chobanian</surname><given-names>A. V.</given-names></name></person-group><year>1990</year><article-title>Effect of fish oil on
atherogenesis in Watanabe heritable hyperlipidemic rabbit</article-title>.
<source>Arteriosclerosis.</source><volume>10</volume>: <fpage>597</fpage>–<lpage>606</lpage>.<pub-id pub-id-type="pmid">2369369</pub-id></mixed-citation>
              </ref>
              <ref id="bib35">
                <label>35.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beltz</surname><given-names>W. F.</given-names></name><name><surname>Kesaniemi</surname><given-names>Y. A.</given-names></name><name><surname>Howard</surname><given-names>B. V.</given-names></name><name><surname>Grundy</surname><given-names>S. M.</given-names></name></person-group><year>1985</year><article-title>Development of an integrated model
for analysis of the kinetics of apolipoprotein B in plasma very low density
lipoproteins, intermediate density lipoproteins, and low density
lipoproteins</article-title>. <source>J. Clin. Invest.</source><volume>76</volume>: <fpage>575</fpage>–<lpage>585</lpage>.<pub-id pub-id-type="pmid">4031063</pub-id></mixed-citation>
              </ref>
              <ref id="bib36">
                <label>36.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Havel</surname><given-names>R. J.</given-names></name></person-group><year>1982</year><article-title>Approach to the patient with
hyperlipidemia</article-title>. <source>Med. Clin. North Am.</source><volume>66</volume>: <fpage>319</fpage>–<lpage>333</lpage>.<pub-id pub-id-type="pmid">7070147</pub-id></mixed-citation>
              </ref>
              <ref id="bib37">
                <label>37.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cortese</surname><given-names>C.</given-names></name><name><surname>Levy</surname><given-names>Y.</given-names></name><name><surname>Janus</surname><given-names>E. D.</given-names></name><name><surname>Turner</surname><given-names>P. R.</given-names></name><name><surname>Rao</surname><given-names>S. N.</given-names></name><name><surname>Miller</surname><given-names>N. E.</given-names></name><name><surname>Lewis</surname><given-names>B.</given-names></name></person-group><year>1983</year><article-title>Modes of action of lipid-lowering
diets in man: studies of apolipoprotein B kinetics in relation to fat consumption
and dietary fatty acid composition</article-title>. <source>Eur. J. Clin.
Invest.</source><volume>13</volume>: <fpage>79</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">6409627</pub-id></mixed-citation>
              </ref>
              <ref id="bib38">
                <label>38.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shepherd</surname><given-names>J.</given-names></name><name><surname>Packard</surname><given-names>C. J.</given-names></name><name><surname>Grundy</surname><given-names>S. M.</given-names></name><name><surname>Yeshurun</surname><given-names>D.</given-names></name><name><surname>Gotto</surname><given-names>A. M.</given-names><suffix>Jr</suffix></name><name><surname>Taunton</surname><given-names>O. D.</given-names></name></person-group><year>1980</year><article-title>Effects of saturated and
polyunsaturated fat diets on the chemical composition and metabolism of low
density lipoproteins in man</article-title>. <source>J. Lipid Res.</source><volume>21</volume>: <fpage>91</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="pmid">7354257</pub-id></mixed-citation>
              </ref>
              <ref id="bib39">
                <label>39.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>J. D.</given-names></name><name><surname>Le</surname><given-names>N. A.</given-names></name><name><surname>Brown</surname><given-names>W. V.</given-names></name></person-group><year>1981</year><article-title>Effect of changing dietary fat
saturation on low-density lipoprotein metabolism in man</article-title>.
<source>Am. J. Physiol.</source><volume>241</volume>: <fpage>E57</fpage>–<lpage>E63</lpage>.<pub-id pub-id-type="pmid">7246768</pub-id></mixed-citation>
              </ref>
              <ref id="bib40">
                <label>40.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouguerram</surname><given-names>K.</given-names></name><name><surname>Maugeais</surname><given-names>C.</given-names></name><name><surname>Gardette</surname><given-names>J.</given-names></name><name><surname>Magot</surname><given-names>T.</given-names></name><name><surname>Krempf</surname><given-names>M.</given-names></name></person-group><year>2006</year><article-title>Effect of n-3 fatty acids on
metabolism of apoB100-containing lipoprotein in type 2 diabetic
subjects</article-title>. <source>Br. J. Nutr.</source><volume>96</volume>: <fpage>100</fpage>–<lpage>106</lpage>.<pub-id pub-id-type="pmid">16869997</pub-id></mixed-citation>
              </ref>
              <ref id="bib41">
                <label>41.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Illingworth</surname><given-names>D. R.</given-names></name><name><surname>Harris</surname><given-names>W. S.</given-names></name><name><surname>Connor</surname><given-names>W. E.</given-names></name></person-group><year>1984</year><article-title>Inhibition of low density
lipoprotein synthesis by dietary omega-3 fatty acids in humans</article-title>.
<source>Arteriosclerosis.</source><volume>4</volume>: <fpage>270</fpage>–<lpage>275</lpage>.<pub-id pub-id-type="pmid">6712540</pub-id></mixed-citation>
              </ref>
              <ref id="bib42">
                <label>42.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>E. A.</given-names></name><name><surname>Pan</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Jamil</surname><given-names>H.</given-names></name><name><surname>Sparks</surname><given-names>J. D.</given-names></name><name><surname>Williams</surname><given-names>K. J.</given-names></name></person-group><year>2001</year><article-title>The triple threat to nascent
apolipoprotein B. Evidence for multiple, distinct degradative
pathways</article-title>. <source>J. Biol. Chem.</source><volume>276</volume>: <fpage>27855</fpage>–<lpage>27863</lpage>.<pub-id pub-id-type="pmid">11285257</pub-id></mixed-citation>
              </ref>
              <ref id="bib43">
                <label>43.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>S. H.</given-names></name><name><surname>Fisher</surname><given-names>E. A.</given-names></name><name><surname>Marsh</surname><given-names>J. B.</given-names></name></person-group><year>1989</year><article-title>Effects of eicosapentaenoic and
docosahexaenoic acids on apoprotein B mRNA and secretion of very low density
lipoprotein in HepG2 cells</article-title>. <source>Arteriosclerosis.</source><volume>9</volume>: <fpage>836</fpage>–<lpage>841</lpage>.<pub-id pub-id-type="pmid">2556098</pub-id></mixed-citation>
              </ref>
              <ref id="bib44">
                <label>44.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>J. L.</given-names></name><name><surname>Furukawa</surname><given-names>S.</given-names></name><name><surname>Ginsberg</surname><given-names>H. N.</given-names></name></person-group><year>1991</year><article-title>Oleate stimulates secretion of
apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early
intracellular degradation of apolipoprotein B</article-title>. <source>J. Biol.
Chem.</source><volume>266</volume>: <fpage>5080</fpage>–<lpage>5086</lpage>.<pub-id pub-id-type="pmid">1848237</pub-id></mixed-citation>
              </ref>
              <ref id="bib45">
                <label>45.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakata</surname><given-names>N.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Dixon</surname><given-names>J. L.</given-names></name><name><surname>Ginsberg</surname><given-names>H. N.</given-names></name></person-group><year>1993</year><article-title>Proteolysis and lipid-facilitated
translocation are distinct but competitive processes that regulate secretion of
apolipoprotein B in Hep G2 cells</article-title>. <source>J. Biol. Chem.</source><volume>268</volume>: <fpage>22967</fpage>–<lpage>22970</lpage>.<pub-id pub-id-type="pmid">8226809</pub-id></mixed-citation>
              </ref>
              <ref id="bib46">
                <label>46.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>G.</given-names></name><name><surname>Windsor</surname><given-names>S. L.</given-names></name><name><surname>Harris</surname><given-names>W. S.</given-names></name></person-group><year>1999</year><article-title>Omega-3 fatty acids alter
lipoprotein subfraction distributions and the in vitro conversion of very low
density lipoproteins to low density lipoproteins</article-title>. <source>J. Nutr.
Biochem.</source><volume>10</volume>: <fpage>151</fpage>–<lpage>158</lpage>.<pub-id pub-id-type="pmid">15539283</pub-id></mixed-citation>
              </ref>
              <ref id="bib47">
                <label>47.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>W. S.</given-names></name><name><surname>Hustvedt</surname><given-names>B. E.</given-names></name><name><surname>Hagen</surname><given-names>E.</given-names></name><name><surname>Green</surname><given-names>M. H.</given-names></name><name><surname>Lu</surname><given-names>G.</given-names></name><name><surname>Drevon</surname><given-names>C. A.</given-names></name></person-group><year>1997</year><article-title>N-3 fatty acids and chylomicron
metabolism in the rat</article-title>. <source>J. Lipid Res.</source><volume>38</volume>: <fpage>503</fpage>–<lpage>515</lpage>.<pub-id pub-id-type="pmid">9101431</pub-id></mixed-citation>
              </ref>
              <ref id="bib48">
                <label>48.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>I. J.</given-names></name><name><surname>Le</surname><given-names>N. A.</given-names></name><name><surname>Paterniti</surname><given-names>J. R.</given-names><suffix>Jr</suffix></name><name><surname>Ginsberg</surname><given-names>H. N.</given-names></name><name><surname>Lindgren</surname><given-names>F. T.</given-names></name><name><surname>Brown</surname><given-names>W. V.</given-names></name></person-group><year>1982</year><article-title>Lipoprotein metabolism during
acute inhibition of hepatic triglyceride lipase in the cynomolgus
monkey</article-title>. <source>J. Clin. Invest.</source><volume>70</volume>: <fpage>1184</fpage>–<lpage>1192</lpage>.<pub-id pub-id-type="pmid">7174789</pub-id></mixed-citation>
              </ref>
              <ref id="bib49">
                <label>49.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>N.</given-names></name><name><surname>Shames</surname><given-names>D. M.</given-names></name><name><surname>Stoudemire</surname><given-names>J. B.</given-names></name><name><surname>Havel</surname><given-names>R. J.</given-names></name></person-group><year>1986</year><article-title>Metabolism of lipoproteins
containing apolipoprotein B-100 in blood plasma of rabbits: heterogeneity related
to the presence of apolipoprotein E</article-title>. <source>Proc. Natl. Acad.
Sci. USA.</source><volume>83</volume>: <fpage>3479</fpage>–<lpage>3483</lpage>.<pub-id pub-id-type="pmid">3458191</pub-id></mixed-citation>
              </ref>
              <ref id="bib50">
                <label>50.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolosi</surname><given-names>R. J.</given-names></name><name><surname>Stucchi</surname><given-names>A. F.</given-names></name><name><surname>Kowala</surname><given-names>M. C.</given-names></name><name><surname>Hennessy</surname><given-names>L. K.</given-names></name><name><surname>Hegsted</surname><given-names>D. M.</given-names></name><name><surname>Schaefer</surname><given-names>E. J.</given-names></name></person-group><year>1990</year><article-title>Effect of dietary fat saturation
and cholesterol on LDL composition and metabolism. In vivo studies of receptor and
nonreceptor-mediated catabolism of LDL in cebus monkeys</article-title>.
<source>Arteriosclerosis.</source><volume>10</volume>: <fpage>119</fpage>–<lpage>128</lpage>.<pub-id pub-id-type="pmid">2297342</pub-id></mixed-citation>
              </ref>
              <ref id="bib51">
                <label>51.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woollett</surname><given-names>L. A.</given-names></name><name><surname>Spady</surname><given-names>D. K.</given-names></name><name><surname>Dietschy</surname><given-names>J. M.</given-names></name></person-group><year>1992</year><article-title>Regulatory effects of the
saturated fatty acids 6:0 through 18:0 on hepatic low density lipoprotein receptor
activity in the hamster</article-title>. <source>J. Clin. Invest.</source><volume>89</volume>: <fpage>1133</fpage>–<lpage>1141</lpage>.<pub-id pub-id-type="pmid">1556178</pub-id></mixed-citation>
              </ref>
              <ref id="bib52">
                <label>52.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hennessy</surname><given-names>L. K.</given-names></name><name><surname>Osada</surname><given-names>J.</given-names></name><name><surname>Ordovas</surname><given-names>J. M.</given-names></name><name><surname>Nicolosi</surname><given-names>R. J.</given-names></name><name><surname>Stucchi</surname><given-names>A. F.</given-names></name><name><surname>Brousseau</surname><given-names>M. E.</given-names></name><name><surname>Schaefer</surname><given-names>E. J.</given-names></name></person-group><year>1992</year><article-title>Effects of dietary fats and
cholesterol on liver lipid content and hepatic apolipoprotein A-I, B, and E and
LDL receptor mRNA levels in cebus monkeys</article-title>. <source>J. Lipid
Res.</source><volume>33</volume>: <fpage>351</fpage>–<lpage>360</lpage>.<pub-id pub-id-type="pmid">1314879</pub-id></mixed-citation>
              </ref>
              <ref id="bib53">
                <label>53.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>M. L.</given-names></name><name><surname>Lin</surname><given-names>E. C.</given-names></name><name><surname>McNamara</surname><given-names>D. J.</given-names></name></person-group><year>1992</year><article-title>Differential effects of saturated
fatty acids on low density lipoprotein metabolism in the guinea
pig</article-title>. <source>J. Lipid Res.</source><volume>33</volume>: <fpage>1833</fpage>–<lpage>1842</lpage>.<pub-id pub-id-type="pmid">1336027</pub-id></mixed-citation>
              </ref>
              <ref id="bib54">
                <label>54.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallim</surname><given-names>T.</given-names></name><name><surname>Salter</surname><given-names>A. M.</given-names></name></person-group><year>2010</year><article-title>Regulation of hepatic gene
expression by saturated fatty acids</article-title>. <source>Prostaglandins
Leukot. Essent. Fatty Acids.</source><volume>82</volume>: <fpage>211</fpage>–<lpage>218</lpage>.<pub-id pub-id-type="pmid">20227267</pub-id></mixed-citation>
              </ref>
              <ref id="bib55">
                <label>55.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>K. G.</given-names></name><name><surname>Maitin</surname><given-names>V.</given-names></name><name><surname>Leake</surname><given-names>D. S.</given-names></name><name><surname>Yaqoob</surname><given-names>P.</given-names></name><name><surname>Williams</surname><given-names>C. M.</given-names></name></person-group><year>2006</year><article-title>Saturated fat-induced changes in
Sf 60–400 particle composition reduces uptake of LDL by HepG2
cells</article-title>. <source>J. Lipid Res.</source><volume>47</volume>: <fpage>393</fpage>–<lpage>403</lpage>.<pub-id pub-id-type="pmid">16278492</pub-id></mixed-citation>
              </ref>
              <ref id="bib56">
                <label>56.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>L. S.</given-names></name><name><surname>Wetterau</surname><given-names>J.</given-names></name><name><surname>Ginsberg</surname><given-names>H. N.</given-names></name></person-group><year>1996</year><article-title>Demonstration of a physical
interaction between microsomal triglyceride transfer protein and apolipoprotein B
during the assembly of ApoB-containing lipoproteins</article-title>. <source>J.
Biol. Chem.</source><volume>271</volume>: <fpage>10277</fpage>–<lpage>10281</lpage>.<pub-id pub-id-type="pmid">8626595</pub-id></mixed-citation>
              </ref>
              <ref id="bib57">
                <label>57.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>E.</given-names></name><name><surname>Stan</surname><given-names>S.</given-names></name><name><surname>Delvin</surname><given-names>E.</given-names></name><name><surname>Menard</surname><given-names>D.</given-names></name><name><surname>Shoulders</surname><given-names>C.</given-names></name><name><surname>Garofalo</surname><given-names>C.</given-names></name><name><surname>Slight</surname><given-names>I.</given-names></name><name><surname>Seidman</surname><given-names>E.</given-names></name><name><surname>Mayer</surname><given-names>G.</given-names></name><name><surname>Bendayan</surname><given-names>M.</given-names></name></person-group><year>2002</year><article-title>Localization of microsomal
triglyceride transfer protein in the Golgi: possible role in the assembly of
chylomicrons</article-title>. <source>J. Biol. Chem.</source><volume>277</volume>: <fpage>16470</fpage>–<lpage>16477</lpage>.<pub-id pub-id-type="pmid">11830580</pub-id></mixed-citation>
              </ref>
              <ref id="bib58">
                <label>58.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>C. A.</given-names></name><name><surname>Hamilton</surname><given-names>R. L.</given-names></name><name><surname>Havel</surname><given-names>R. J.</given-names></name></person-group><year>1976</year><article-title>Subcellular localization of B
apoprotein of plasma lipoproteins in rat liver</article-title>. <source>J. Cell
Biol.</source><volume>69</volume>: <fpage>241</fpage>–<lpage>263</lpage>.<pub-id pub-id-type="pmid">177430</pub-id></mixed-citation>
              </ref>
              <ref id="bib59">
                <label>59.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A. M.</given-names></name><name><surname>Baker</surname><given-names>P. W.</given-names></name><name><surname>Gibbons</surname><given-names>G. F.</given-names></name></person-group><year>1997</year><article-title>Changes in fatty acid metabolism
in rat hepatocytes in response to dietary n-3 fatty acids are associated with
changes in the intracellular metabolism and secretion of apolipoprotein
B-48</article-title>. <source>J. Lipid Res.</source><volume>38</volume>: <fpage>469</fpage>–<lpage>481</lpage>.<pub-id pub-id-type="pmid">9101428</pub-id></mixed-citation>
              </ref>
              <ref id="bib60">
                <label>60.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murthy</surname><given-names>S.</given-names></name><name><surname>Albright</surname><given-names>E.</given-names></name><name><surname>Mathur</surname><given-names>S. N.</given-names></name><name><surname>Davidson</surname><given-names>N. O.</given-names></name><name><surname>Field</surname><given-names>F. J.</given-names></name></person-group><year>1992</year><article-title>Apolipoprotein B mRNA abundance is
decreased by eicosapentaenoic acid in CaCo-2 cells. Effect on the synthesis and
secretion of apolipoprotein B</article-title>. <source>Arterioscler.
Thromb.</source><volume>12</volume>: <fpage>691</fpage>–<lpage>700</lpage>.<pub-id pub-id-type="pmid">1591230</pub-id></mixed-citation>
              </ref>
              <ref id="bib61">
                <label>61.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>E.</given-names></name><name><surname>Spahis</surname><given-names>S.</given-names></name><name><surname>Ziv</surname><given-names>E.</given-names></name><name><surname>Marette</surname><given-names>A.</given-names></name><name><surname>Elchebly</surname><given-names>M.</given-names></name><name><surname>Lambert</surname><given-names>M.</given-names></name><name><surname>Delvin</surname><given-names>E.</given-names></name></person-group><year>2006</year><article-title>Overproduction of intestinal
lipoprotein containing apolipoprotein B-48 in Psammomys obesus: impact of dietary
n-3 fatty acids</article-title>. <source>Diabetologia.</source><volume>49</volume>: <fpage>1937</fpage>–<lpage>1945</lpage>.<pub-id pub-id-type="pmid">16788801</pub-id></mixed-citation>
              </ref>
              <ref id="bib62">
                <label>62.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>S. H.</given-names></name><name><surname>Marsh</surname><given-names>J. B.</given-names></name></person-group><year>1988</year><article-title>Inhibition of apolipoprotein
secretion and phosphatidate phosphohydrolase activity by eicosapentaenoic and
docosahexaenoic acids in the perfused rat liver</article-title>.
<source>Metabolism.</source><volume>37</volume>: <fpage>1177</fpage>–<lpage>1181</lpage>.<pub-id pub-id-type="pmid">2848178</pub-id></mixed-citation>
              </ref>
              <ref id="bib63">
                <label>63.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calleja</surname><given-names>L.</given-names></name><name><surname>Trallero</surname><given-names>M. C.</given-names></name><name><surname>Carrizosa</surname><given-names>C.</given-names></name><name><surname>Mendez</surname><given-names>M. T.</given-names></name><name><surname>Palacios-Alaiz</surname><given-names>E.</given-names></name><name><surname>Osada</surname><given-names>J.</given-names></name></person-group><year>2000</year><article-title>Effects of dietary fat amount and
saturation on the regulation of hepatic mRNA and plasma apolipoprotein A-I in
rats</article-title>. <source>Atherosclerosis.</source><volume>152</volume>: <fpage>69</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="pmid">10996341</pub-id></mixed-citation>
              </ref>
              <ref id="bib64">
                <label>64.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayek</surname><given-names>T.</given-names></name><name><surname>Ito</surname><given-names>Y.</given-names></name><name><surname>Azrolan</surname><given-names>N.</given-names></name><name><surname>Verdery</surname><given-names>R. B.</given-names></name><name><surname>Aalto-Setala</surname><given-names>K.</given-names></name><name><surname>Walsh</surname><given-names>A.</given-names></name><name><surname>Breslow</surname><given-names>J. L.</given-names></name></person-group><year>1993</year><article-title>Dietary fat increases high density
lipoprotein (HDL) levels both by increasing the transport rates and decreasing the
fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I.
Presentation of a new animal model and mechanistic studies in human Apo A-I
transgenic and control mice</article-title>. <source>J. Clin. Invest.</source><volume>91</volume>: <fpage>1665</fpage>–<lpage>1671</lpage>.<pub-id pub-id-type="pmid">8473509</pub-id></mixed-citation>
              </ref>
              <ref id="bib65">
                <label>65.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwab</surname><given-names>D. A.</given-names></name><name><surname>Rea</surname><given-names>T. J.</given-names></name><name><surname>Hanselman</surname><given-names>J. C.</given-names></name><name><surname>Bisgaier</surname><given-names>C. L.</given-names></name><name><surname>Krause</surname><given-names>B. R.</given-names></name><name><surname>Pape</surname><given-names>M. E.</given-names></name></person-group><year>2000</year><article-title>Elevated hepatic apolipoprotein
A-I transcription is associated with diet-induced hyperalphalipoproteinemia in
rabbits</article-title>. <source>Life Sci.</source><volume>66</volume>: <fpage>1683</fpage>–<lpage>1694</lpage>.<pub-id pub-id-type="pmid">10809165</pub-id></mixed-citation>
              </ref>
              <ref id="bib66">
                <label>66.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vessby</surname><given-names>B.</given-names></name><name><surname>Boberg</surname><given-names>J.</given-names></name><name><surname>Gustafsson</surname><given-names>I. B.</given-names></name><name><surname>Karlstrom</surname><given-names>B.</given-names></name><name><surname>Lithell</surname><given-names>H.</given-names></name><name><surname>Ostlund-Linqvist</surname><given-names>A. M.</given-names></name></person-group><year>1980</year><article-title>Reduction of high density
lipoprotein cholesterol and apoliproprotein A-I concentrations by a lipid-lowering
diet</article-title>. <source>Atherosclerosis.</source><volume>35</volume>: <fpage>21</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="pmid">6768372</pub-id></mixed-citation>
              </ref>
              <ref id="bib67">
                <label>67.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azrolan</surname><given-names>N.</given-names></name><name><surname>Odaka</surname><given-names>H.</given-names></name><name><surname>Breslow</surname><given-names>J. L.</given-names></name><name><surname>Fisher</surname><given-names>E. A.</given-names></name></person-group><year>1995</year><article-title>Dietary fat elevates hepatic
apoA-I production by increasing the fraction of apolipoprotein A-I mRNA in the
translating pool</article-title>. <source>J. Biol. Chem.</source><volume>270</volume>: <fpage>19833</fpage>–<lpage>19838</lpage>.<pub-id pub-id-type="pmid">7649994</pub-id></mixed-citation>
              </ref>
              <ref id="bib68">
                <label>68.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vélez-Carrasco</surname><given-names>W.</given-names></name><name><surname>Lichtenstein</surname><given-names>A. H.</given-names></name><name><surname>Welty</surname><given-names>F. K.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Lamon-Fava</surname><given-names>S.</given-names></name><name><surname>Dolnikowski</surname><given-names>G. G.</given-names></name><name><surname>Schaefer</surname><given-names>E. J.</given-names></name></person-group><year>1999</year><article-title>Dietary restriction of saturated
fat and cholesterol decreases HDL ApoA-I secretion</article-title>.
<source>Arterioscler. Thromb. Vasc. Biol.</source><volume>19</volume>: <fpage>918</fpage>–<lpage>924</lpage>.<pub-id pub-id-type="pmid">10195918</pub-id></mixed-citation>
              </ref>
              <ref id="bib69">
                <label>69.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furtado</surname><given-names>J. D.</given-names></name><name><surname>Campos</surname><given-names>H.</given-names></name><name><surname>Appel</surname><given-names>L. J.</given-names></name><name><surname>Miller</surname><given-names>E. R.</given-names></name><name><surname>Laranjo</surname><given-names>N.</given-names></name><name><surname>Carey</surname><given-names>V. J.</given-names></name><name><surname>Sacks</surname><given-names>F. M.</given-names></name></person-group><year>2008</year><article-title>Effect of protein, unsaturated
fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL
containing apolipoprotein C-III: results from the OmniHeart Trial</article-title>.
<source>Am. J. Clin. Nutr.</source><volume>87</volume>: <fpage>1623</fpage>–<lpage>1630</lpage>.<pub-id pub-id-type="pmid">18541549</pub-id></mixed-citation>
              </ref>
              <ref id="bib70">
                <label>70.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>C.</given-names></name><name><surname>Khoo</surname><given-names>C.</given-names></name><name><surname>Furtado</surname><given-names>J.</given-names></name><name><surname>Sacks</surname><given-names>F. M.</given-names></name></person-group><year>2010</year><article-title>Apolipoprotein C-III and the
metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein
phenotype</article-title>. <source>Circulation.</source><volume>121</volume>: <fpage>1722</fpage>–<lpage>1734</lpage>.<pub-id pub-id-type="pmid">20368524</pub-id></mixed-citation>
              </ref>
              <ref id="bib71">
                <label>71.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langsted</surname><given-names>A.</given-names></name><name><surname>Freiberg</surname><given-names>J. J.</given-names></name><name><surname>Nordestgaard</surname><given-names>B. G.</given-names></name></person-group><year>2008</year><article-title>Fasting and nonfasting lipid
levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins,
and cardiovascular risk prediction</article-title>. <source>Circulation.</source><volume>118</volume>: <fpage>2047</fpage>–<lpage>2056</lpage>.<pub-id pub-id-type="pmid">18955664</pub-id></mixed-citation>
              </ref>
              <ref id="bib72">
                <label>72.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordestgaard</surname><given-names>B. G.</given-names></name><name><surname>Benn</surname><given-names>M.</given-names></name><name><surname>Schnohr</surname><given-names>P.</given-names></name><name><surname>Tybjaerg-Hansen</surname><given-names>A.</given-names></name></person-group><year>2007</year><article-title>Nonfasting triglycerides and risk
of myocardial infarction, ischemic heart disease, and death in men and
women</article-title>. <source>J. Am. Med. Assoc.</source><volume>298</volume>: <fpage>299</fpage>–<lpage>308</lpage>.</mixed-citation>
              </ref>
              <ref id="bib73">
                <label>73.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bansal</surname><given-names>S.</given-names></name><name><surname>Buring</surname><given-names>J. E.</given-names></name><name><surname>Rifai</surname><given-names>N.</given-names></name><name><surname>Mora</surname><given-names>S.</given-names></name><name><surname>Sacks</surname><given-names>F. M.</given-names></name><name><surname>Ridker</surname><given-names>P. M.</given-names></name></person-group><year>2007</year><article-title>Fasting compared with nonfasting
triglycerides and risk of cardiovascular events in women</article-title>.
<source>J. Am. Med. Assoc.</source><volume>298</volume>: <fpage>309</fpage>–<lpage>316</lpage>.</mixed-citation>
              </ref>
              <ref id="bib74">
                <label>74.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacks</surname><given-names>F. M.</given-names></name><name><surname>Katan</surname><given-names>M.</given-names></name></person-group><year>2002</year><article-title>Randomized clinical trials on the
effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular
disease</article-title>. <source>Am. J. Med.</source><volume>113</volume> (<issue>suppl.</issue>):
<fpage>13</fpage>–<lpage>24</lpage>.</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
